<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_OMTN1870 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEgr5 jpg ?>
<?FILEgr6 jpg ?>
<?FILEgr7 jpg ?>
<?FILEfx1 jpg ?>
<?FILEmmc1 pdf ?>
<?FILEmmc2 xls ?>
<?FILEmmc3 xls ?>
<?FILEmmc4 xls ?>
<?FILEmmc5 xls ?>
<?FILEmmc6 pdf ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mol Ther Nucleic Acids</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mol Ther Nucleic Acids</journal-id>
    <journal-title-group>
      <journal-title>Molecular Therapy. Nucleic Acids</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2162-2531</issn>
    <publisher>
      <publisher-name>American Society of Gene &amp; Cell Therapy</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10149290</article-id>
    <article-id pub-id-type="pii">S2162-2531(23)00073-2</article-id>
    <article-id pub-id-type="doi">10.1016/j.omtn.2023.03.014</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Landscape and significance of human super enhancer-driven core transcription regulatory circuitry</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au1">
        <name>
          <surname>Feng</surname>
          <given-names>Chenchen</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au2">
        <name>
          <surname>Song</surname>
          <given-names>Chao</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au3">
        <name>
          <surname>Jiang</surname>
          <given-names>Yong</given-names>
        </name>
        <xref rid="aff8" ref-type="aff">8</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au4">
        <name>
          <surname>Zhao</surname>
          <given-names>Jun</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au5">
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au6">
        <name>
          <surname>Wang</surname>
          <given-names>Yuezhu</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au7">
        <name>
          <surname>Yin</surname>
          <given-names>Mingxue</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au8">
        <name>
          <surname>Zhu</surname>
          <given-names>Jiang</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au9">
        <name>
          <surname>Ai</surname>
          <given-names>Bo</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au10">
        <name>
          <surname>Wang</surname>
          <given-names>Qiuyu</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
      </contrib>
      <contrib contrib-type="author" id="au11">
        <name>
          <surname>Qian</surname>
          <given-names>Fengcui</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au12">
        <name>
          <surname>Zhang</surname>
          <given-names>Yuexin</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au13">
        <name>
          <surname>Shang</surname>
          <given-names>Desi</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
      </contrib>
      <contrib contrib-type="author" id="au14">
        <name>
          <surname>Liu</surname>
          <given-names>Jiaqi</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au15">
        <name>
          <surname>Li</surname>
          <given-names>Chunquan</given-names>
        </name>
        <email>lcqbio@163.com</email>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <aff id="aff1"><label>1</label>School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China</aff>
      <aff id="aff2"><label>2</label>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff3"><label>3</label>School of Computer, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff4"><label>4</label>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Affiliated Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff5"><label>5</label>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff6"><label>6</label>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff7"><label>7</label>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff8"><label>8</label>Medical Research Institute, Wuhan University, Wuhan 430000, China</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Corresponding author: Chunquan Li, School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China. <email>lcqbio@163.com</email></corresp>
      <fn id="fn1">
        <label>9</label>
        <p id="ntpara0010">These authors contributed equally</p>
      </fn>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <day>13</day>
      <month>6</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <volume>32</volume>
    <fpage>385</fpage>
    <lpage>401</lpage>
    <history>
      <date date-type="received">
        <day>3</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>3</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder/>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract id="abs0010">
      <p>A core transcription regulatory circuitry (CRC) is an interconnected self-regulatory circuitry that is formed by a group of core transcription factors (TFs). These core TFs collectively regulate gene expression by binding not only to their own super enhancers (SEs) but also to the SEs of one another. For most human tissue/cell types, a global view of CRCs and core TFs has not been generated. Here, we identified numerous CRCs using two identification methods and detailed the landscape of the CRCs driven by SEs in large cell/tissue samples. The comprehensive biological analyses, including sequence conservation, CRC activity and genome binding affinity were conducted for common TFs, moderate TFs, and specific TFs, which exhibit different biological features. The local module located from the common CRC network highlighted the essential functions and prognostic performance. The tissue-specific CRC network was highly related to cell identity. Core TFs in tissue-specific CRC networks exhibited disease markers, and had regulatory potential for cancer immunotherapy. Moreover, a user-friendly resource named CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0010">http://www.licpathway.net/crcdb/index.html</ext-link>) was developed, which contained the detailed information of CRCs and core TFs used in this study, as well as other interesting results, such as the most representative CRC, frequency of TFs, and indegree/outdegree of TFs.</p>
    </abstract>
    <abstract abstract-type="graphical" id="abs0015">
      <title>Graphical abstract</title>
      <fig id="undfig1" position="anchor">
        <graphic xlink:href="fx1"/>
      </fig>
    </abstract>
    <abstract abstract-type="teaser" id="abs0020">
      <p>Li and colleagues describe numerous CRCs and provide comprehensive human CRC models in massive cell/tissue samples. Our work generates significant and extensive insights into the transcriptomic and epigenomic landscape of SE-driven CRCs and highlights the functional and regulatory roles of core TFs in maintaining cell identity and disease regulation.</p>
    </abstract>
    <kwd-group id="kwrds0010">
      <title>Keywords</title>
      <kwd>MT: Bioinformatics</kwd>
      <kwd>core transcription regulatory circuitry</kwd>
      <kwd>transcription factor</kwd>
      <kwd>super enhancer</kwd>
      <kwd>network analysis</kwd>
      <kwd>platform</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p id="p0010">Gene transcription is a complex cellular process involving a variety of enzymes and organelles. As <italic>trans</italic>-acting factors, transcription factors (TFs) are important components of regulatory gene transcription networks.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> TFs are often coupled with proteins to form regulatory complexes, which bind promoters or enhancers of genes, participate in gene transcription, and affect gene expression. Thus, TFs are an indispensable part of cellular activities.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> There are a small number of master TFs that dominate the control of gene expression programs governing cell state and cell identity in a cell-type-specific or lineage-specific manner.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Within a given cell type, some TFs work together to regulate their own genes, and many others. They bind to not only their own genes but also those of the other TFs, forming interconnected self-regulatory circuitry, termed core transcription regulatory circuitry (CRC).<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> TFs within the CRCs are considered as the core TFs for a specific cell type.</p>
    <p id="p0015">Core TFs enrich genes associated with a variety of diseases or traits and provide an effective means of discovering cellular identity genes and reprogramming genes.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> For example, the core TFs <italic>OCT4</italic>, <italic>SOX2</italic>, and <italic>NANOG</italic> collaborate to play essential roles in early cell development and contribute to the establishment and maintenance of embryonic stem cell identity.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Genome-wide chromatin immunoprecipitation followed by sequencing (ChIP-seq) analyses demonstrated that a small number of core TFs, including <italic>MYCN</italic>, <italic>HAND2</italic>, <italic>ISL1</italic>, <italic>PHOX2B</italic>, <italic>GATA3</italic>, and <italic>TBX2</italic>, maintain cell state and survival in <italic>MYCN</italic>-amplified neuroblastomas.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Recent studies also showed that the core TFs forming CRCs play a crucial role in the development of cancer by binding to super enhancers (SEs) to activate the transcription of specific genes in cells.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> They bind not only to their own SEs but also to the SEs of each other. By analyzing 21 cases of rhabdomyosarcoma, Gryder et al. identified the core TFs <italic>SOX8</italic>, <italic>MYOD1</italic>, and <italic>MYOG</italic>.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> These TFs, which are regulated by highly acetylated SEs, bound not only to their own SEs but also to SEs associated with other important genes, thereby affecting the fate of the entire cell. Jiang et al. established a CRC model mediated by core TFs and SEs in esophageal squamous cell carcinoma (ESCC), and found the core TFs, <italic>TP63</italic>, <italic>SOX2</italic>, and <italic>KLF5</italic>, to be part of a CRC network that determined chromatin accessibility, epigenetic modifications, and gene expression patterns in ESCC cells.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> Collectively, CRCs provide a novel strategy to study the gene expression programs and transcription patterns that control cellular identity and to better understand transcriptional abnormalities in diseases. However, for most cell types, an understanding of the core TFs and CRCs is limited. The identification of CRCs in various cell/tissue types will be valuable for studies of transcriptional regulation of specific cell types in healthy and diseased states.</p>
    <p id="p0020">The classical <italic>CRC mapper</italic> algorithm was developed to identify CRC models of human cell types, in which core TFs are encoded by genes associated with SEs. SEs have high signal densities for H3K27ac and were identified from H3K27ac ChIP-seq data.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Aldiri et al. used <italic>CRC mapper</italic> to identify the dynamic CRC landscape of the retina during development, reprogramming, and tumorigenesis.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Lin et al. used <italic>CRC mapper</italic> to reconstruct CRCs to identify core TFs associated with subgroup divergence and subgroup-specific cellular origins.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> The assay for transposase-accessible chromatin using sequencing (ATAC-seq) is also an effective technology for identifying regulatory element regions.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> The combination of ChIP-seq and ATAC-seq data may be used to more accurately identify hypersensitive TF-binding elements within large enhancer regions. A python package, <italic>Coltron</italic> (<ext-link ext-link-type="uri" xlink:href="https://pypi.python.org/pypi/coltron" id="intref0015">https://pypi.python.org/pypi/coltron</ext-link>), has been developed to identify CRCs by integrating H3K27ac ChIP-seq and ATAC-seq data. Ott et al. used <italic>Coltron</italic> to identify the CRCs of chronic lymphocytic leukemia (CLL) cells and completely characterized the active <italic>cis</italic>-regulatory landscape of the CLL epigenome.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> They found that <italic>PAX5</italic> was regulated by SEs and played a dominant role in CLL and was essential for cell survival. BET bromodomain inhibitors prevented the expression of intracellular SE-dependent genes, selectively inhibited the CRCs of CLL, and had effective antitumor activity. Thus, different algorithms demonstrated their advantages and the integration of the two approaches provided the greater success in CRC reconstruction.</p>
    <p id="p0025">Motivated by the identification of CRCs in various cell/tissue types and the systematic study of SE-driven CRC mechanisms, this study identified CRCs and core TFs using <italic>CRC mapper</italic> and <italic>Coltron</italic>, and generated the landscape of CRCs driven by SEs. Notably, the study identified a large number of CRCs in human cells/tissues and extensive human CRC models. We also conducted a comprehensive biological analysis of these CRCs and core TFs. First, we calculated and compared the CRCs and core TFs using the two methods, and divided core TFs into common TFs, moderate TFs, and specific TFs to validate the different biological features among them, including sequence conservation, CRC activity, and genome binding affinity. Second, a fully connected module was located from a common CRC network. Functional enrichment analyses highlighted the essential functions maintained by the modules of the common CRC networks. Survival analysis suggested that the module provided clinical guidance for cancer prognosis. Third, tissue-specific TF-TF interactions were used to construct tissue-specific CRC networks, which were highly related to cell identity. The core TFs in tissue-specific CRC networks could include disease markers, and have regulatory potential for cancer immunotherapy. Finally, to extend the impact and use of CRCs across human cells/tissues, we developed a user-friendly resource platform named CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0020">http://www.licpathway.net/crcdb/index.html</ext-link>). CRCdb can integrate global information of core TFs, SEs, and TF genes, and the regulatory element interactions within CRC networks.</p>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>Identification and description of CRCs in multiple cell/tissue types</title>
      <p id="p0030">In this study, we obtained H3K27ac ChIP-seq data from NCBI GEO/SRA,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> ENCODE,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Roadmap,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> and GGR.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> We identified SEs and their elements in a large number of cell/tissue samples. Based on the closest active genes of the SEs, two identification methods, <italic>CRC mapper</italic> and <italic>Coltron</italic>, were used to systematically identify CRCs driven by SEs. Then, the resource platform CRCdb was developed to present the extensive annotation information on CRCs and core TFs (<xref rid="fig1" ref-type="fig">Figure 1</xref>A). In total, 367,495 and 8,235,853 CRCs were identified from ∼500 samples by the two methods, respectively. Approximately 500 core TFs formed these CRCs in more than 50 tissues, binding to more than 30,000 SEs (<xref rid="fig1" ref-type="fig">Figure 1</xref>B; <xref rid="mmc2" ref-type="supplementary-material">Table S1</xref>). We then compared the TF overlap ratios of the two methods across 22 major tissues. The results showed that <italic>Coltron</italic> identified more core TFs than <italic>CRC mapper</italic>, and nearly 50%–70% of the core TFs were identified by both methods, indicating that H3k27ac peaks or valleys recruited different core TFs (<xref rid="fig1" ref-type="fig">Figure 1</xref>C; <xref rid="mmc3" ref-type="supplementary-material">Table S2</xref>). Heart tissue had the highest number of core TFs. Seventy-two overlapped TFs identified by the two methods were obtained from the heart tissue samples (the TF list is provided in <xref rid="mmc3" ref-type="supplementary-material">Table S2</xref>). We performed functional enrichment for these TFs, and the results showed that all TFs were enriched in cardiovascular-related diseases, including the known cardiovascular disease genes <italic>TBX5</italic>, <italic>TBX20</italic>, <italic>STAT3</italic>, <italic>MEF2A</italic>, <italic>MEIS1</italic>, <italic>HIF1A</italic>, and <italic>GATA4</italic> (<xref rid="fig1" ref-type="fig">Figure 1</xref>D). Those results inspired us to investigate the role of common TFs and specific TFs in different biological characteristics.<fig id="fig1"><label>Figure 1</label><caption><p>Identification and description of CRCs in multiple cell/tissue types</p><p>(A) Data sources and research contents. (B) Statistical data. (C) TF overlap ratios of 2 methods across 22 major tissues. In the histogram, pink represents <italic>Coltron</italic> and green represents <italic>CRC mapper</italic>. The x axis represents the tissue name and the y axis represents the number of TFs. In the pie chart, red represents the overlap ratio of TFs in the two methods and blue represents the specific ratio. (D) The overlapping TFs from the two methods identified in heart tissue enriched in cardiovascular-related diseases. The x axis is the enriched disease name and the y axis is the number of TFs. The color of the dot represents the significance level. The redder the color, the higher the significance level of the enrichment. The size of dot represents the number of enriched TFs. The larger the dots, the more TFs were enriched. (E) The distribution of core TFs present in different numbers of cell/tissue types using the two methods. The color represents the number of tissue types. (F) Heatmap of the specific and common TFs based on the TF occurrences (1 or 0) in different tissue/cell samples. <italic>AR</italic> and <italic>NKX3-</italic><italic>1</italic> appeared in the prostate, <italic>PAX3</italic> appeared in skeletal muscle.</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0035">To reveal the distribution of CRCs, the frequency of core TFs present in different cell/tissue types was counted. The <italic>CRC mapper</italic> results showed that 12.2% of core TFs were only present in one cell/tissue type, while the <italic>Coltron</italic> results showed that 9.8% of core TFs were only present in one cell/tissue type. In addition, the maximum number of core TFs appeared in between 2 and 30 cell/tissue types. A small number of core TFs appeared in more than 30 cell/tissue types using both methods (<xref rid="fig1" ref-type="fig">Figure 1</xref>E). Furthermore, we calculated the specific TFs and common TFs based on the TF occurrences in different samples. The results showed that some known markers were identified in specific cell/tissue type, such as <italic>AR</italic> and <italic>NKX3-</italic><italic>1</italic> in prostate cells and <italic>PAX3</italic> in skeletal muscle (<xref rid="fig1" ref-type="fig">Figure 1</xref>F). The results demonstrated that CRCs and core TFs had different distributions and characteristics in different cell/tissue types. Some CRCs and core TFs occurred specifically in a few tissues, while others were common in most tissues, thus, requiring further classification research.</p>
    </sec>
    <sec id="sec2.2">
      <title>The specific and common TFs of CRCs exhibit different biological characteristics</title>
      <p id="p0040">We identified CRCs and their core TFs in numerous human cell/tissue types. By counting the number of core TFs that appeared in different numbers of cell/tissue types, <italic>Coltron</italic> identified 53 core TFs present in only 1 tissue, while 36 core TFs were present in more than 35 tissues. <italic>CRC mapper</italic> exhibited similar results, with 62 core TFs identified in only one cell/tissue, and 34 core TFs present in more than 35 cells/tissues (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). Based on those results, we defined the core TFs in only one cell/tissue as “specific” and those in more than 35 cells/tissues as “common.” The other core TFs that appeared in between 2 and 35 cell/tissue types were defined as “moderate.” The common TFs were similar in both methods, while the specific TFs were largely different (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). Thus, the common TFs were prevalent in some common tissues and tended to perform essential functions. However, the specific TFs tended to perform specific functions and varied greatly in different tissues. For example, we identified that the AP-1 family, including <italic>FOS</italic>, <italic>JUN</italic>, <italic>JUNB</italic>, and <italic>JUND</italic> were common TFs, and composed the CRCs in more than 35 tissues. Previous study validated that the AP-1 family of TFs plays fundamental roles in cell differentiation, proliferation, and apoptosis.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Some TFs, such as <italic>RARA</italic>, <italic>SMAD3</italic>, <italic>KLF7</italic>, <italic>BCL6</italic>, <italic>FOXO3</italic>, <italic>RUNX1</italic>, and <italic>NR2F2</italic>, were also classified as common TFs, which have been implicated in the regulation of gene activity, cell proliferation, cell death, and tumor survival.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="bib19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="bib20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> However, <italic>AR</italic> in prostate cells,<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref>
<italic>POU1F1</italic> in brain tissue,<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref>
<italic>SHOX</italic> in bone,<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref>
<italic>ZSCAN4</italic> in placenta tissue,<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> and <italic>VSX2</italic> in retina<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> were considered specific TFs in this study. Those TFs have been shown to function in specific tissues by TF marker, which is a comprehensive manually curated database of TFs and related markers with experimental evidence from human-specific cell/tissue types.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref><fig id="fig2"><label>Figure 2</label><caption><p>Biological characteristics of specific and common TFs</p><p>(A) Core TFs in only one cell/tissue are “specific” TFs, core TFs in more than 35 cells/tissues are “common” TFs, and core TFs in 2–35 cell/tissue types are “moderate” TFs. The x axis is the number of tissues and the y axis is the number of TFs. The pie charts in the middle represent the overlap of common and specific TFs between the two methods, respectively. (B) The number of SEs that specific, common, and moderate TFs bind to. The x axis is the number of tissues and the y axis is the number of SEs. (C) Conservation score (two-tailed log rank test, p&lt;0.05) of specific, moderate, and common TFs, respectively. (D) CRC activity score (two-tailed log rank test, p&lt;0.05) of specific, moderate, and common TFs, respectively. (E) The genome binding features of the common TF, <italic>JUND</italic>, and the specific TF, <italic>AR</italic>, based on TF ChIP-seq data. (F) The binding affinity to the SEs of <italic>JUND</italic> and <italic>AR</italic>.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0045">SE is composed of many active enhancer elements, which can be bound by protein complexes composed of various TFs and transcription cofactors, thereby regulating the expression level of related genes and ultimately affecting cell fate.<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> In a CRC, multiple core TFs bind to their own SEs and the SEs of each other to regulate the expression of TF genes. In this study, we observed the number of SEs that specific, moderate, and common TFs bound to. The results showed that common TFs bound to the largest number of SEs, while the specific TFs bound to the smallest number of SEs (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). Those data suggested that common TFs tended to perform similar regulatory functions in different cells by binding to more common SEs, while specific TFs play specific roles in maintaining cell identity, which can be achieved by binding to the relatively few tissue-specific SEs.</p>
      <p id="p0050">We calculated the conservation score and CRC activity score of specific, moderate, or common TFs. As expected, the most conserved group of core TFs was that of the common TFs (two-tailed log rank test, p &lt; 0.05, <xref rid="fig2" ref-type="fig">Figure 2</xref>C). This was expected as common TFs are the most highly conserved TF class across all common cell/tissue types. We also found that specific TFs had the highest CRC activity scores (two-tailed log rank test, p &lt; 0.05, <xref rid="fig2" ref-type="fig">Figure 2</xref>D), implying the significant role of specific TFs on tissue-specific regulation. Moreover, we compared the genome binding features of diverse TF types based on TF ChIP-seq data. The results showed that the common TF <italic>JUND</italic> had more similar binding features in different tissues than the specific TF <italic>AR</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>E). Notably, we found that <italic>AR</italic> bound more distal regions in prostate cell lines than other non-specific tissues, implying that TFs preferred to exert important functions by binding to the distal regions. This result suggested that TFs maintain cell identity and control tissue-specific regulation based on their binding to distal enhancers and SEs. The results also showed that the <italic>JUND</italic> peaks revealed the binding affinity to the SEs of <italic>JUND</italic> across multiple tissues; however, only prostate-related <italic>AR</italic> peaks revealed the binding affinity to the SEs of <italic>AR</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>F).</p>
    </sec>
    <sec id="sec2.3">
      <title>Local modules in common CRC networks play important biological functions</title>
      <p id="p0055">The transcriptional state of a cell emerges from an underlying gene regulatory network in which a limited number of TFs and cofactors regulate each other and their downstream target genes. Thus, we counted the number of TF-TF interactions of CRCs that appeared in different numbers of cell/tissue types, and showed their distribution (<xref rid="fig3" ref-type="fig">Figure 3</xref>A). Then, all the TF-TF interactions of CRCs that appeared in more than 15 cell/tissue types were integrated into a common CRC network. Analysis of the common CRC network can provide a global view of the regulatory relationships involved in the interactions among core TFs. However, the common CRC network was a huge network with a large number of core TF nodes and their interactions. It is difficult to find more detailed information from such a huge network and, therefore, we located local modules to reveal the detailed modular organization. Based on the common CRC network, a fully connected module consisting of 18 core TF nodes was identified (<xref rid="fig3" ref-type="fig">Figure 3</xref>B). According to gene expression data from GTEx,<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> Pearson correlation coefficients (PCCs) were calculated between any two core TFs in the module. The 18 core TFs showed positive correlation with each other to varying degrees (<xref rid="fig3" ref-type="fig">Figure 3</xref>C, upper triangle). Meanwhile, we counted the overlap of the 18 core TFs in the one-step neighbors of the common CRC network. The results showed that the TFs shared many of the same one-step neighbors in the network (<xref rid="fig3" ref-type="fig">Figure 3</xref>C, lower triangle). Those results demonstrated that the core TFs of the module were structurally closely connected, expressed positive correlation, and tended to cluster together to perform important biological functions.<fig id="fig3"><label>Figure 3</label><caption><p>The features of local modules in common CRC networks</p><p>(A) The distribution of TF-TF interactions of CRCs in different numbers of cell/tissue types. Different colors represent different numbers of tissue types. The larger the area of the rings, the more TF-TF interactions. (B) A fully connected module consisted of 18 core TF nodes. (C) The upper triangle represents PCCs between any two core TFs in the module. The depth of the color represents the level of the PCC score. The darker the color, the greater the score. The lower triangle represents the shared one-step neighbors between any two core TFs in the common CRC network. The color and size of the node represents the number of shared one-step neighbors. The large and blue nodes represent the more shared one-step neighbors; the small and red nodes represent the fewer shared one-step neighbors. The x axis and y axis represent the 18 core TFs of module. (D) GO and KEGG enrichment analyses with hypergeometric test p &lt; 0.01 for the 18 core TFs. (E) Different mutation frequencies among the 18 core TFs. (F) The HR of the module in different tumor patients. The x axis represents the disease name and the y axis represents the TF name. The color represents the log10(HR). (G) Overall survival curves of the module in KIRC, LGG, and pan-cancer patients with two-tailed log rank test p &lt; 0.001.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0060">GO and KEGG enrichment analyses found that the core TFs of the module were significantly involved in the functions of cell differentiation, nucleus, positive regulation of transcription, TF activity, transcription regulatory region sequence-specific DNA binding, and transcriptional misregulation in cancer (hypergeometric test, p &lt; 0.01, <xref rid="fig3" ref-type="fig">Figure 3</xref>D). Those results agreed with our expectations. TFs control numerous cellular processes, including proliferation, differentiation, apoptosis, and inflammation. Abnormal TF activity has been implicated in a variety of diseases, especially cancer. The correct subcellular localization of TFs determines their activation status, implicating the nuclear transport receptors as key players in regulating TF function. Dysregulation of the nuclear transport machinery has been described in multiple cancer types.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> We next explored the mutations among the core TFs in the module and found different mutation frequencies (<xref rid="fig3" ref-type="fig">Figure 3</xref>E). The core TFs in the module all participated in similar biological processes and jointly participated in transcriptional regulation-related molecular functions.</p>
      <p id="p0065">To further assess the prognostic performance of the module, survival analysis was performed on the 18 core TFs. From the results of the Cox proportional hazards model, we found that the module had different hazard ratio (HR) values in different tumor patients (<xref rid="fig3" ref-type="fig">Figure 3</xref>F). In particular, most of the core TFs in the module had HR values less than 1 in kidney renal clear cell carcinoma (KIRC) patients, which indicated that the core TFs of the module were protective factors in KIRC and played a protective role in the survival of KIRC patients. On the contrary, most of the core TFs in the module had HR values greater than 1 in brain lower-grade glioma (LGG) patients, which means that the core TFs were injurious factors in LGG and harmful to LGG patient survival. Kaplan-Meier survival curves were plotted for the KIRC, LGG, and pan-cancer patient groups. Consistent with the above HR results, KIRC patients in the low-risk score group had a significantly shorter overall survival than those in the high-risk score group (two-tailed log rank test, p = 1.0e−05, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). However, for LGG patients, the overall survival time of the high-risk group was significantly shorter than that of low-risk group (two-tailed log rank test, p = 2.7e−05, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). The module also exhibited good prognostic performance in pan-cancer patients (two-tailed log rank test, p = 4.5e−08, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). Those findings indicated that the local module in the common CRC network provided clinical guidance for cancer prognosis.</p>
    </sec>
    <sec id="sec2.4">
      <title>Specific network analysis reveals tissue-specific CRC networks</title>
      <p id="p0070">After deep excavation, we not only found that some common TF-TF interactions in the CRCs appeared in more than 15 cell/tissue types but, also, a number of specific TF-TF interactions only appeared in one kind of cell/tissue type. In addition, the results in <xref rid="fig1" ref-type="fig">Figure 1</xref>C suggest that nearly half of the core TFs were non-redundant between the <italic>Coltron</italic> and <italic>CRC mapper</italic> methods. Thus, we calculated the frequencies of TF-TF interactions in CRCs in several major human cell/tissue types using both methods (<xref rid="fig4" ref-type="fig">Figure 4</xref>A). It should be noted that there was a small subset of specific TF-TF interactions that only appeared in one major cell/tissue type. Those interactions were considered as tissue-specific TF-TF interactions. Hypergeometric tests identified substantial overlap between the core TFs of the tissue-specific TF-TF interactions and TFs in a TF-marker database<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> with p values less than 0.01 (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). In heart tissue and prostate tissue, in particular, there was significantly more overlapped TFs (hypergeometric test, p &lt; 0.01, <xref rid="fig4" ref-type="fig">Figure 4</xref>B). The results indicated that the core TFs of the tissue-specific TF-TF interactions in CRCs could be used as marker genes, which were the signatures in specific cells and tissues.<fig id="fig4"><label>Figure 4</label><caption><p>Analysis of tissue-specific CRC networks</p><p>(A) The frequency of TF-TF interactions of the CRCs in several major cell/tissue types. The x axis represents the tissue name. Different colors represent different numbers of tissue types. (B) The overlap between core TFs of the tissue-specific CRC network and marker TFs in the TF-marker database (hypergeometric test, p &lt; 0.01). The color of the dots represents the significance level. The redder the dot, the higher the significance level. (C) A heart-specific CRC network. The size of the dot represents the degree. The larger the dot, the greater the degree. The gene names in red represent the hub nodes. (D) A prostate-specific CRC network. The size of the dot represents the degree. The larger the dot, the greater the degree. The gene names in red represent the hub nodes. (E) The overlap between the target genes of core TFs in the tissue-specific CRC network across multiple tissues. The overlap between heart and muscle tissues was statistically significant (p &lt; 10e−22). The overlap between bone marrow and blood tissues was statistically significant (p &lt; 10e−22).</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0075">Heart-tissue-specific TF-TF interactions and prostate-tissue-specific TF-TF interactions were obtained to construct a heart-specific CRC network and a prostate-specific CRC network, respectively (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). From the two networks, we can see that some core TFs had relatively greater node degrees. Studies found that the node degree of genes in biological networks represents their regulatory potential; therefore, we defined the top 10 core TFs with the greatest node degrees as the hub nodes. For example, in the heart-specific CRC network, <italic>ZNF524</italic>, <italic>NKX2-</italic><italic>5</italic>, <italic>TBX20</italic>, <italic>CEBPD</italic>, <italic>ERF</italic>, <italic>ATF5</italic>, <italic>HLF</italic>, <italic>SP2</italic>, <italic>HBP1</italic>, and <italic>GATA4</italic>, were defined as the hub nodes (<xref rid="fig4" ref-type="fig">Figure 4</xref>C). It is worth noting that the hubs regulated more other nodes in the network and contained some known heart-related TFs. <italic>NKX2-</italic><italic>5</italic> is a key TF in early cardiac development, which regulates not only the initiation but also the usage of poly(A) sites during heart development.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref>
<italic>TBX20</italic> is a T-box TF that plays essential roles in the development and maintenance of the heart. <italic>T</italic><italic>BX</italic><italic>20</italic> has been reported to be critical for mammalian cardiac development and function.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> In a similar way, <italic>HOXB13</italic>, <italic>NKX3-</italic><italic>1</italic>, <italic>NFAT5</italic>, <italic>ELK4</italic>, <italic>IRX5</italic>, <italic>SP8</italic>, <italic>AR</italic>, <italic>SPDEF</italic>, <italic>DLX2</italic>, and <italic>ISL1</italic> were identified as hub nodes in the prostate-specific CRC network (<xref rid="fig4" ref-type="fig">Figure 4</xref>D). Those hubs were associated with more regulatory relationships than the other nodes in the network, showing stronger regulatory potential. The androgen receptor (<italic>AR</italic>) is a major regulator of lipid metabolism, controlling the expression of more than 20 enzymes involved in the synthesis, uptake, and metabolism of lipids.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> The <italic>AR</italic> has been widely recognized as a key driver of prostate cancer. In addition, <italic>HOXB13</italic> is a member of the homeobox family TFs, which is expressed mainly in the adult prostate and at a much lower level in the colorectum.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> Transgenic mice studies have shown that <italic>HOXB13</italic> expression is required for epithelial differentiation of the ventral prostate.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Taken together, these results demonstrated that tissue-specific CRC networks can capture specific core TFs, some of which are markers for diseases and exist as hubs in the network.</p>
      <p id="p0080">We also detected the overlap between the target genes of core TFs in the tissue-specific CRC network in major human cell/tissue types. Core TFs regulate the expression of their target genes by directly binding to their SEs. Different tissues have exhibited substantial overlap between target genes (<xref rid="fig4" ref-type="fig">Figure 4</xref>E). For example, the overlap between heart and muscle tissues was identified with a hypergeometric p value &lt;10e−22. The heart is a muscle composed of specially differentiated muscle cells, many of which are clustered and surrounded by connective tissue into muscle bundles.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> Similarly, the overlap between bone marrow and blood tissues was also identified with a hypergeometric p value &lt;10e−22. Those results suggest that core TFs acting as hubs in the tissue-specific CRC networks regulate the expression of relatively more target genes, and that similarities may exist between the target genes in different diseases.</p>
    </sec>
    <sec id="sec2.5">
      <title>Significance of prostate-specific CRC network</title>
      <p id="p0085">Next, we used the prostate-specific CRC network to investigate the potential role and significance of tissue-specific CRC networks in cancer biology. The top 10 core TFs with the greatest node degree were selected for further analysis, including <italic>HOXB13</italic>, <italic>NKX3-</italic><italic>1</italic>, <italic>NFAT5</italic>, <italic>ELK4</italic>, <italic>IRX5</italic>, <italic>SP8</italic>, <italic>AR</italic>, <italic>SPDEF</italic>, <italic>DLX2</italic>, and <italic>ISL1</italic>. First, we compared the average expression of these TFs across cancers. They were exceptionally highly expressed in prostate cancer (<xref rid="fig5" ref-type="fig">Figure 5</xref>A), suggesting that these TFs functioned in a tissue-specific pattern and were crucial for the pathological processes of prostate cancer. Then, we used the GREAT tool<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> to perform function analyses for the binding SEs of the core TFs in prostate-related samples, and found that the binding SEs were highly related to the proliferation of prostate epithelium and prostate development (<xref rid="fig5" ref-type="fig">Figure 5</xref>B). We further calculated the TCGA ATAC-seq signal in these SE regions. The results showed that the activity of ATAC-seq peaks within these SEs were higher than other background peaks (rank sum test, p &lt;0.001, <xref rid="fig5" ref-type="fig">Figure 5</xref>C). Moreover, GWAS SNP mapping results showed that these SEs could enrich the prostate-related SNPs (<xref rid="fig5" ref-type="fig">Figure 5</xref>D). The above results indicated that the core TFs of the tissue-specific CRC networks had broad regulatory effects in tissue-specific biology.<fig id="fig5"><label>Figure 5</label><caption><p>Significance of the prostate-specific CRC network</p><p>(A) The expression distribution of the top 10 core TFs with the greatest degree of the prostate-specific CRC network in different cancers. The x axis represents the cancer name and the y axis indicates the RPKM value. (B) Function annotation for the binding SEs of the top 10 core TFs. (C) TCGA ATAC-seq signal in SE regions and other background peaks (rank sum test, p &lt; 0.001). (D) GWAS SNP mapping results of the SEs. (E) TIMER2 results of multiple immune cells. (F) The correlations between core TFs and the cell infiltration levels of immune cells. <italic>AR</italic>, <italic>NFAT5</italic>, and <italic>SPEDF</italic> are positively or negatively correlated with immune cell infiltration.</p></caption><graphic xlink:href="gr5"/></fig></p>
      <p id="p0090">Previous studies suggested that immunotherapy is effective in cancer.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref><sup>,</sup><xref rid="bib41" ref-type="bibr"><sup>41</sup></xref><sup>,</sup><xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> Immunotherapy is re-emerging as a viable option for prostate cancer, especially castration-resistant prostate cancer, to stimulate antitumor immunity.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> The TIMER2 results showed that multiple immune cells exhibited high infiltration in prostate cancers, including dendritic cells, CD8<sup>+</sup> T cells, and neutrophils (<xref rid="fig5" ref-type="fig">Figure 5</xref>E). We then evaluated the correlations between core TFs and the cell infiltration levels of immune cells using expression data and TIMER2 data. The results showed that some core TFs were positively or negatively correlated with immune cell infiltration, such as <italic>AR</italic>, <italic>NFAT5</italic>, and <italic>SPEDF</italic>, thus suggesting that these TFs had potential regulatory effects on tumor microenvironments (<xref rid="fig5" ref-type="fig">Figure 5</xref>F). We identified that the expression of the prostate-specific core TF, <italic>AR</italic>, was highly related to CD8<sup>+</sup> T cell infiltration (PCC = 0.85), indicating the crosstalk between <italic>AR</italic> and CD8<sup>+</sup> T cell activity. Interestingly, Guan et al. found that blocking <italic>AR</italic> sensitized tumor-bearing hosts to effective checkpoint blockade by directly enhancing CD8<sup>+</sup> T cell function.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref>
<italic>AR</italic> inhibited the activity and stemness of male tumor-infiltrating CD8+ T cells by regulating epigenetic and transcriptional differentiation programs.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> These results suggested that prostate cancer cells might resist CD8<sup>+</sup> cell infiltration by upregulating the expression of <italic>AR</italic>. <italic>SPDEF</italic> was revealed as a tumor suppressor in prostate cancer by disrupting a positive feedback loop in the regulation of F<italic>OXM</italic>1.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> In airway epithelial cells, overexpression of <italic>SPDEF</italic> inhibited LPS-induced neutrophilic infiltration and bacterial clearance.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> We inferred that <italic>SPDEF</italic> could regulate neutrophil infiltration to overcome prostate cancer. <italic>NFAT5</italic> was not investigated in prostate cancer or immune cell infiltration, but the results showed that <italic>NFAT5</italic> was highly related to multiple immune cell infiltrations, which could be considered as possible immunotherapy targets in prostate cancer patients. Furthermore, we also investigated the regulatory potentials of tissue-specific CRC network-driven core TFs on immune infiltration in other tumors, such as colon adenocarcinoma, glioblastoma multiforme, lung adenocarcinoma, pancreatic adenocarcinoma, and uterine carcinosarcoma (UCS) (<xref rid="mmc1" ref-type="supplementary-material">Figure S1</xref>). Numerous core TFs of the tissue-specific CRC network, such as <italic>ASCL2</italic>, <italic>SOX6</italic>, <italic>TBX5</italic>, <italic>FOXP2</italic>, and <italic>SOX17</italic>, were identified as candidate regulators in tumor immunotherapy, which can interfere with tumor cell growth by regulating the activity of immune cells.</p>
    </sec>
    <sec id="sec2.6">
      <title>CRCdb, a platform for the landscape of CRCs and core TFs</title>
      <p id="p0095">To bridge the gap between big data information and biologists, we developed a user-friendly resource platform, CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0025">http://www.licpathway.net/crcdb/index.html</ext-link>), to identify the CRCs of human cell/tissue types. The current version of CRCdb documents over 500 samples from NCBI, ENCODE, and Roadmap. For all samples, CRCs were identified using a unified system environment, taking advantage of <italic>Coltron</italic> and <italic>CRC mapper</italic>. The number of human samples has been increased nearly 3-fold compared with the existing database and the scale of data is five times larger than the existing database. The number of CRCs in CRCdb is 8,611,549. CRCdb also provides detailed information of CRCs (the most representative CRC and all other CRCs), supporting the display of frequency of TFs in CRCs and the indegree/outdegree of TFs. Users can easily browse CRCdb content through a user-friendly interface.</p>
      <p id="p0100">Using CRCdb, there are three ways to scan the CRCs and core TFs. First, users can choose “sample-based browse” or “TF-based browse” and scan the detailed CRC information in different cell/tissue types on the browse page (<xref rid="fig6" ref-type="fig">Figures 6</xref>A–6G). Second, users can search and view information of interest in a targeted way through clicking “search CRC by sample-based,” “search CRC by TF-based,” or “search CRC by tissue-based” (<xref rid="fig6" ref-type="fig">Figures 6</xref>H–6K). Furthermore, three kinds of analytical strategies allow users to perform detailed analyses of CRCs, core TFs, SEs, and SE-associated TF genes (<xref rid="fig6" ref-type="fig">Figure 6</xref>L). In addition, download links are provided for users to batch download information.<fig id="fig6"><label>Figure 6</label><caption><p>Overview of CRCdb</p><p>(A–G) Detailed CRC information in different cell/tissue types on the “Browse” page. (H–K) Detailed CRC information through “Search” function. (L) Three types of analytical strategies.</p></caption><graphic xlink:href="gr6"/></fig></p>
    </sec>
    <sec id="sec2.7">
      <title>Case study of downstream gene-based CRC analysis in CRCdb</title>
      <p id="p0105">We performed “Analyze CRCs by Downstream gene” by inputting cardiac marker genes (<italic>NKX2-</italic><italic>5</italic>, <italic>MEF2C</italic>, and <italic>MEF2D</italic>) as the gene input list to evaluate CRCdb for fields related to cardiovascular functions and diseases (<xref rid="fig7" ref-type="fig">Figure 7</xref>A). The analytical results returned core TFs in CRCs associated with the input genes, including <italic>ATF3</italic>, <italic>GATA4</italic>, <italic>JUN</italic>, <italic>MEF2C</italic>, <italic>NR4A1</italic>, and <italic>TBX5</italic> (<xref rid="fig7" ref-type="fig">Figure 7</xref>B). The SE distribution table for these core TFs showed that most SEs were distributed in heart tissue-related samples (<xref rid="fig7" ref-type="fig">Figure 7</xref>C). For example, SEs associated with <italic>JUN</italic>, <italic>GATA4</italic>, and <italic>TBX5</italic> were mainly distributed in right cardiac atrium tissues. SEs associated with <italic>JUN</italic>, <italic>NR4A1</italic>, <italic>GATA4</italic>, and <italic>MEF2C</italic> were mainly distributed in coronary artery tissues. These findings were consistent with previous findings that the upstream enhancer of <italic>NKX2-</italic><italic>5</italic> had high binding affinity to <italic>GATA4</italic>,<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> thus, suggesting that core TFs in SE-driven CRCs can enhance the transcription of <italic>NKX2-</italic><italic>5</italic> in cardiac development. Other SE-regulated core TF-gene pairs have also identified potential interactions during heart development, the dysregulation of which can result in the occurrence of cardiovascular diseases.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> The ranked plot for SEs with the highest median H3K27ac scores were developed for each TF (<xref rid="fig7" ref-type="fig">Figure 7</xref>D). By clicking the sample ID, users can further obtain detailed information about CRCs and core TFs in specific tissue. For example, when clicking “Sample_02_381,” users can view a brief overview of the most representative CRC model (<xref rid="fig7" ref-type="fig">Figure 7</xref>E). More information about the frequency of core TFs in CRCs and the indegree/outdegree of core TFs are provided to the users (<xref rid="fig7" ref-type="fig">Figure 7</xref>E). Generally, the higher the frequency of a TF, the more important the TF is under this sample. A TF with high indegree and outdegree values is also considered to be an important TF. Thus, <italic>GATA4</italic> and <italic>NR4A1</italic> become the most important core TFs under this sample. Collectively, we performed a specific case study of CRC analysis for cardiac tissue in CRCdb. The annotated core TFs have been shown to be directly related to cardiovascular-related diseases. The results revealed the significance of our platform for research of CRCs and core TFs in human tissues.<fig id="fig7"><label>Figure 7</label><caption><p>Results of a case study in CRCdb</p><p>(A) Three cardiac marker genes (<italic>NKX2-</italic><italic>5</italic>, <italic>MEF2C</italic>, and <italic>MEF2D</italic>) as the gene input list to perform “Analyze CRCs by Downstream gene” function in the “Analysis” page. (B) All of the core TFs in CRCs associated with the input genes, including <italic>ATF3</italic>, <italic>GATA4</italic>, <italic>JUN</italic>, <italic>MEF2C</italic>, <italic>NR4A1</italic>, and <italic>TBX5</italic>. (C) SE distribution table related to the core TFs in CRCs. (D) Ranked plot for the SEs with the highest median H3K27ac scores. (E) Detailed information of “Sample_02_381”.</p></caption><graphic xlink:href="gr7"/></fig></p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p id="p0110">TFs play a key regulatory role in cellular activities and affect the normal growth and differentiation of human cells and tissues. Many tremendous advances have been made for the control of transcription,<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> but the core TFs of CRCs that control gene expression programs have yet to be mapped in most human tissues/cells. The CRCs driven by SEs can be used to analyze the coordinated regulation of intracellular TFs.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> The core TFs that constitute the CRCs are conducive to the discovery of key regulatory genes.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> Thus, this study described a model of CRCs driven by SEs for ∼500 human cell and tissue samples, thus providing a foundation for comprehensive studies of core transcription regulatory programs in diverse human cell/tissue types. The integration of the <italic>Coltron</italic> and <italic>CRC mapper</italic> methods was validated to capture more comprehensive information than each method individually. The CRCs and core TFs exhibited different distributions in different cell/tissue types. Some were only present in a few cells/tissues, while others were common in most cells/tissues. Thus, the core TFs were classified into “specific,” “common,” and “moderate.” We found that specific and common TFs exhibited different characteristics, including different genome binding affinities, sequence conservation, and CRC activity. <italic>JUND</italic> was a common TF and <italic>AR</italic> was a specific TF. It is also worth noting that <italic>JUND</italic> displayed similar binding features in different tissues, but <italic>AR</italic> bound more distal regions only in prostate cell lines. In addition, <italic>JUND</italic> binding peaks revealed binding affinity to the SEs of <italic>JUND</italic> across multiple tissues, but only prostate-related <italic>AR</italic> peaks bound to the SEs of <italic>AR</italic>.</p>
    <p id="p0115">Transcription regulatory networks (TRNs) provide important information in revealing the essence of gene transcription. Numerous gene expression-based methods have been proposed to construct TRNs, such as <italic>GENIE3</italic><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> and <italic>ARACNe</italic>,<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> using random forest and mutual information, respectively. Compared with epigenetics data-based methods, <italic>Coltron</italic> and <italic>CRC mapper</italic>, gene expression-based methods have advantages in identifying more TF-TF interactions, but also produce more false positive results. Mechanically, TFs participate in transcription regulation to control cell identity by binding to DNA regulatory regions, including enhancers and SEs. The TF-TF interactions identified in our epigenetics data-based methods were based on the TF binding affinity of SEs. The results of our study validated the regulatory effects of these TF-TF interactions in specific tissues. In addition, we used the top 10 core TFs with the greatest node degree in the prostate-specific CRC network (<xref rid="fig5" ref-type="fig">Figure 5</xref>A) as a case to illustrate the differences between the epigenetics data-based methods and gene expression-based methods. Furthermore, we constructed TRNs by inputting the human TF list and gene expression matrix for prostate adenocarcinoma in TCGA, using the <italic>GENIE3</italic> and <italic>ARACNe</italic> methods, respectively. The TF-TF subnetworks were extracted from the TRNs by inputting core TFs from our prostate-specific CRC network. The top 10 TFs were subsequently obtained by calculating the node degree of the subnetworks. Only two intersections of the top 10 TFs (<italic>HOXB13</italic> and <italic>NKX3-</italic><italic>1</italic>) could be identified by all the methods (<xref rid="mmc1" ref-type="supplementary-material">Figure S2</xref>), implying that gene expression-based methods are insufficient to reproduce the results that were returned from the epigenetics data-based methods.</p>
    <p id="p0120">The return of a gene node to the network reveals its global properties and topological features. Therefore, we extracted the common TF-TF interactions of CRCs that appeared in more than 15 cell/tissue types to construct a common CRC network. The TFs of the fully connected module in the common CRC network expressed positive correlation, shared many same one-step neighbors, and performed good prognostic performance. We also focused on a number of specific TF-TF interactions that only appeared in one kind of cell/tissue type, which were used for constructing the tissue-specific CRC network. Core TFs in the tissue-specific CRC network could capture disease markers and were shown to be highly related to cell identity. Cancer immunotherapy experiments further suggested that the core TFs in the tissue-specific CRC network had potential regulatory effects on the tumor microenvironment.</p>
    <p id="p0125">To detail the landscape of human SE-driven CRCs, a user-friendly platform, CRCdb, was developed. It contains the detailed information of CRCs and core TFs analyzed in this study, as well as some other information of CRCs that were not discussed in this study, such as the most representative CRC, frequency of TFs in CRCs, and indegree/outdegree of TFs. Users can easily browse the CRCdb content through a user-friendly interface.</p>
    <p id="p0130">In summary, our work provides fundamental and extensive insights into the transcriptomic and epigenomic landscape of human CRCs and highlights the functional and regulatory roles of core TFs in maintaining cell identity and disease regulation. Remarkably, the study provided a large quantity of CRCs and extremely comprehensive human CRC models in massive human cell/tissue samples. With the continual accumulation of data, we will extend the scale of the CRCs and investigate the regulatory roles in the single-cell perspective, as well as update our CRCdb platform. We believe that CRCdb is a useful and effective platform for exploring and elucidating TF functions in complex diseases. Continued investigation of the human CRCs identified here will greatly improve our understanding of the mechanisms of TF-related therapies.</p>
  </sec>
  <sec id="sec4">
    <title>Materials and methods</title>
    <sec id="sec4.1">
      <title>Data sourcing and filtering</title>
      <p id="p0135">This study integrated a large volume of H3K27ac ChIP-seq data from NCBI GEO/SRA,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> ENCODE,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Roadmap,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> and GGR.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> In these public databases, we entered the keyword “H3K27ac” to search for samples, and obtained information for more than 2,000 original samples, including cell/tissue type, treatment condition, and sample number. In the process of screening NCBI GEO/SRA data, all samples were manually verified according to the unique sample number to ensure that all sample data were unique and non-redundant. Ultimately, 542 publicly available human samples were collected from the four public data sources for this study. To ensure the quality of SE identification, each sample collected had to contain H3K27ac data and the INPUT data for the corresponding controls.</p>
    </sec>
    <sec id="sec4.2">
      <title>Global recognition of SEs and related genes in large samples</title>
      <p id="p0140">In this study, to ensure the accuracy and popularity of SE recognition, we used ROSE<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> to identify SEs in 542 human samples. We also completed the construction of a pipeline that mainly included sequence alignment, format conversion, H3K27ac peak identification, and SE identification. Based on these steps, this study identified 331,601 SEs and 1,992,738 SE elements in 542 samples.</p>
      <p id="p0145">Numerous studies have shown that calculating the read density of H3K27ac around transcription start sites can be used to estimate which genes are expressed in cells or tissues. In this study, <italic>CRC mapper</italic><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> was used to calculate the read density of H3K27ac in the ±1 kb region around the transcription start site (namely, the promoter region) of each transcript in each sample, and the gene transcripts were ranked according to the density. Then, the gene transcripts were assigned to the gene, and the duplicated genes were deleted. Finally, we obtained the closest active genes of the SE based on their proximity.</p>
    </sec>
    <sec id="sec4.3">
      <title>Systematic identification and evaluation of CRCs driven by SEs</title>
      <p id="p0150">To identify the CRCs, <italic>CRC mapper</italic><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> was used with sequence alignment data, the H3K27ac peaks identified by MACS,<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> and the enhancer output files from ROSE.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> The identification of CRCs was performed as follows: (1) using the results of SE regions and alignment results to calculate the closest active genes, (2) screening the part of the closest active genes that are TFs and find the TFs regulated by SEs, (3) TF motifs were collected from TRANSFAC<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref> and JASPAR<xref rid="bib61" ref-type="bibr"><sup>61</sup></xref> databases, (4) FIMO in MEME<xref rid="bib62" ref-type="bibr"><sup>62</sup></xref> was used for motif scanning of the sequences of the SE elements. The scanning region of SE was limited to the SE elements and not all regions because such element regions were the binding regions of most TFs. The p value threshold of FIMO was 1 × 10<sup>−4</sup>, (5) a TF was defined as a self-regulatory TF when it could bind to an SE element that regulates the TF. Then, all the self-regulatory TFs bound to the SE of a sample were calculated, and the self-regulatory circuitry with complete interconnection of all the TFs was constructed using a recursive calculation, which was used as the model for all CRCs of the sample.</p>
      <p id="p0155">Many regulatory circuitries can be identified in a sample, and some studies have taken the most representative regulatory circuitry ranked first as the preferred CRC. However, a large number of studies have found that sometimes other regulatory circuitries not ranked first also play important roles. Therefore, in this study, all the regulatory circuitries identified by a sample were regarded as the CRCs of the sample, and they were integrated for analysis. After calculating the CRCs, the TFs composing them were defined as core TFs, which were all driven and regulated by SEs. Finally, 367,495 CRCs and 508 core TFs were successfully identified in 514 samples.</p>
      <p id="p0160">The other script used in this study to identify the CRCs was <italic>Coltron</italic> (<ext-link ext-link-type="uri" xlink:href="https://pypi.python.org/pypi/coltron" id="intref0030">https://pypi.python.org/pypi/coltron</ext-link>). Compared with <italic>CRC mapper</italic>, <italic>Coltron</italic> used sequence alignment data, H3K27ac valleys, and enhancer output files from ROSE. Another protocol was in line with “CRC mapper.” As a result, 8,235,853 CRCs and 541 core TFs were successfully identified in 483 samples.</p>
    </sec>
    <sec id="sec4.4">
      <title>Multi-omics data of core TFs</title>
      <p id="p0165">TF-related disease information was downloaded from DisGeNET.<xref rid="bib63" ref-type="bibr"><sup>63</sup></xref> TF gene expression data were downloaded from GTEx.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> TF expression data across TCGA cancers were downloaded from UCSC Xena (<ext-link ext-link-type="uri" xlink:href="http://xena.ucsc.edu/" id="intref0035">http://xena.ucsc.edu/</ext-link>). H3K27ac, <italic>JUND</italic>, and <italic>AR</italic> ChIP-seq data from different tissues were downloaded from Cistrome and ENCODE databases.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> The clinical information of tumor patients, including their survival status, stage, grade, survival time, and response to chemotherapy, were downloaded from the TCGA project. ChIPseeker was performed to view the peak annotation distributions.<xref rid="bib64" ref-type="bibr"><sup>64</sup></xref> For genomic data, the variation information for core TFs was downloaded from cBioPortal (<ext-link ext-link-type="uri" xlink:href="http://cbioportal.org" id="intref0040">http://cbioportal.org</ext-link>).</p>
    </sec>
    <sec id="sec4.5">
      <title>Construction of common/tissue-specific CRC networks</title>
      <p id="p0170">In a given cell type, the core TFs in a CRC interconnected with each other, forming a fully connected network. All of the CRC networks identified by <italic>Coltron</italic> and <italic>CRC mapper</italic> are provided in <xref rid="mmc4" ref-type="supplementary-material">Tables S3</xref> and <xref rid="mmc5" ref-type="supplementary-material">S4</xref>. We listed the TF-TF interaction pairs of CRCs that appeared in different numbers of cell/tissue types. The pairs that appeared in more than 15 cell/tissue types were considered as common TF-TF interactions and integrated to construct a common CRC network. The pairs that only appeared in one cell/tissue type were considered as tissue-specific TF-TF interactions. Among them, heart-tissue-specific TF-TF interactions and prostate-tissue-specific TF-TF interactions were obtained to construct a heart-specific CRC network and a prostate-specific CRC network, respectively.</p>
      <p id="p0175">Based on the common CRC network, a fully connected module was located using CFinder software, which is a platform independent, stand-alone application that locates overlapping groups of densely interconnected nodes in graphs.<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref></p>
    </sec>
    <sec id="sec4.6">
      <title>Function annotation</title>
      <p id="p0180">GO annotation and KEGG enrichment analyses were carried out using the R package, clusterProfiler.<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> Statistical significance was calculated using the hypergeometric test with p values less than 0.01.</p>
    </sec>
    <sec id="sec4.7">
      <title>Survival analysis</title>
      <p id="p0185">We constructed a Cox proportional hazards model, the interpretation of which was done using HR. HR was defined as the ratio of the predicted hazard function under two different values of a predictor variable.</p>
      <p id="p0190">The risk score for each patient was computed by the linear combination of the gene expression values weighted by the regression coefficient of the univariate Cox regression analysis, which was defined as follows:<disp-formula id="ufd1"><mml:math id="M1" altimg="si1.gif"><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">k</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mi>Exp</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula></p>
      <p id="p0195">where r<sub>i</sub> is the Cox regression coefficient of gene i in the gene set, n is the number of genes in the gene set, and Exp(i) is the expression value of gene i in corresponding patient. The median risk score was used to classify patients into high-risk and low-risk groups.</p>
      <p id="p0200">Kaplan-Meier survival curves were plotted using the R survival package. Statistical significance was assessed using a two-tailed log rank test with a p value threshold of less than 0.01.</p>
    </sec>
    <sec id="sec4.8">
      <title>Immune cell infiltration of TFs in prostate cancer patients</title>
      <p id="p0205">Infiltration estimation scores for all cancer patients were downloaded from TIMER2.0,<xref rid="bib67" ref-type="bibr"><sup>67</sup></xref> which contained six immune cell infiltration levels. The potential roles of core TFs in cell infiltration were estimated by calculating the correlation between TF expression and the infiltration estimation scores.</p>
    </sec>
  </sec>
  <sec sec-type="data-availability" id="sec4.9">
    <title>Data availability</title>
    <p id="p0210">Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.</p>
  </sec>
</body>
<back>
  <ref-list id="cebib0010">
    <title>References</title>
    <ref id="bib1">
      <label>1</label>
      <element-citation publication-type="journal" id="sref1">
        <person-group person-group-type="author">
          <name>
            <surname>Lambert</surname>
            <given-names>S.A.</given-names>
          </name>
          <name>
            <surname>Jolma</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Campitelli</surname>
            <given-names>L.F.</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>P.K.</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Albu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Taipale</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Hughes</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Weirauch</surname>
            <given-names>M.T.</given-names>
          </name>
        </person-group>
        <article-title>The human transcription factors</article-title>
        <source>Cell</source>
        <volume>172</volume>
        <year>2018</year>
        <fpage>650</fpage>
        <lpage>665</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.029</pub-id>
        <pub-id pub-id-type="pmid">29425488</pub-id>
      </element-citation>
    </ref>
    <ref id="bib2">
      <label>2</label>
      <element-citation publication-type="journal" id="sref2">
        <person-group person-group-type="author">
          <name>
            <surname>Fuxman Bass</surname>
            <given-names>J.I.</given-names>
          </name>
          <name>
            <surname>Sahni</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Garcia-Gonzalez</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Vidal</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Walhout</surname>
            <given-names>A.J.M.</given-names>
          </name>
        </person-group>
        <article-title>Human gene-centered transcription factor networks for enhancers and disease variants</article-title>
        <source>Cell</source>
        <volume>161</volume>
        <year>2015</year>
        <fpage>661</fpage>
        <lpage>673</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2015.03.003</pub-id>
        <pub-id pub-id-type="pmid">25910213</pub-id>
      </element-citation>
    </ref>
    <ref id="bib3">
      <label>3</label>
      <element-citation publication-type="journal" id="sref3">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Plummer</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y.Y.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>T.C.</given-names>
          </name>
          <name>
            <surname>Gull</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>L.W.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma</article-title>
        <source>Gut</source>
        <volume>69</volume>
        <year>2020</year>
        <fpage>630</fpage>
        <lpage>640</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2019-318325</pub-id>
        <pub-id pub-id-type="pmid">31409603</pub-id>
      </element-citation>
    </ref>
    <ref id="bib4">
      <label>4</label>
      <element-citation publication-type="journal" id="sref4">
        <person-group person-group-type="author">
          <name>
            <surname>Boyer</surname>
            <given-names>L.A.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>M.F.</given-names>
          </name>
          <name>
            <surname>Johnstone</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>S.S.</given-names>
          </name>
          <name>
            <surname>Zucker</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Guenther</surname>
            <given-names>M.G.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>H.L.</given-names>
          </name>
          <name>
            <surname>Jenner</surname>
            <given-names>R.G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Core transcriptional regulatory circuitry in human embryonic stem cells</article-title>
        <source>Cell</source>
        <volume>122</volume>
        <year>2005</year>
        <fpage>947</fpage>
        <lpage>956</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id>
        <pub-id pub-id-type="pmid">16153702</pub-id>
      </element-citation>
    </ref>
    <ref id="bib5">
      <label>5</label>
      <element-citation publication-type="journal" id="sref5">
        <person-group person-group-type="author">
          <name>
            <surname>Whyte</surname>
            <given-names>W.A.</given-names>
          </name>
          <name>
            <surname>Orlando</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Hnisz</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Kagey</surname>
            <given-names>M.H.</given-names>
          </name>
          <name>
            <surname>Rahl</surname>
            <given-names>P.B.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Master transcription factors and mediator establish super-enhancers at key cell identity genes</article-title>
        <source>Cell</source>
        <volume>153</volume>
        <year>2013</year>
        <fpage>307</fpage>
        <lpage>319</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id>
        <pub-id pub-id-type="pmid">23582322</pub-id>
      </element-citation>
    </ref>
    <ref id="bib6">
      <label>6</label>
      <element-citation publication-type="journal" id="sref6">
        <person-group person-group-type="author">
          <name>
            <surname>Durbin</surname>
            <given-names>A.D.</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>M.W.</given-names>
          </name>
          <name>
            <surname>Dharia</surname>
            <given-names>N.V.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Iniguez</surname>
            <given-names>A.B.</given-names>
          </name>
          <name>
            <surname>Weichert-Leahey</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Krill-Burger</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Root</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Vazquez</surname>
            <given-names>F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry</article-title>
        <source>Nat. Genet.</source>
        <volume>50</volume>
        <year>2018</year>
        <fpage>1240</fpage>
        <lpage>1246</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0191-z</pub-id>
        <pub-id pub-id-type="pmid">30127528</pub-id>
      </element-citation>
    </ref>
    <ref id="bib7">
      <label>7</label>
      <element-citation publication-type="journal" id="sref7">
        <person-group person-group-type="author">
          <name>
            <surname>Ott</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>L.S.</given-names>
          </name>
          <name>
            <surname>Kasar</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Klitgaard</surname>
            <given-names>J.L.</given-names>
          </name>
          <name>
            <surname>Lenci</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Lawlor</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Souza</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia</article-title>
        <source>Cancer Cell</source>
        <volume>34</volume>
        <year>2018</year>
        <fpage>982</fpage>
        <lpage>995.e7</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2018.11.001</pub-id>
        <pub-id pub-id-type="pmid">30503705</pub-id>
      </element-citation>
    </ref>
    <ref id="bib8">
      <label>8</label>
      <element-citation publication-type="journal" id="sref8">
        <person-group person-group-type="author">
          <name>
            <surname>Gryder</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Pomella</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sayers</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X.S.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Chiarella</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Bagchi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>H.C.</given-names>
          </name>
          <name>
            <surname>Sinniah</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Walton</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma</article-title>
        <source>Nat. Genet.</source>
        <volume>51</volume>
        <year>2019</year>
        <fpage>1714</fpage>
        <lpage>1722</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0534-4</pub-id>
        <pub-id pub-id-type="pmid">31784732</pub-id>
      </element-citation>
    </ref>
    <ref id="bib9">
      <label>9</label>
      <element-citation publication-type="journal" id="sref9">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Y.Y.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C.Q.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Dakle</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>J.W.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>R.Y.T.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>J.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TP63, SOX2, and KLF5 establish a core regulatory circuitry that controls epigenetic and transcription patterns in esophageal squamous cell carcinoma cell lines</article-title>
        <source>Gastroenterology</source>
        <volume>159</volume>
        <year>2020</year>
        <fpage>1311</fpage>
        <lpage>1327.e19</lpage>
        <pub-id pub-id-type="doi">10.1053/j.gastro.2020.06.050</pub-id>
        <pub-id pub-id-type="pmid">32619460</pub-id>
      </element-citation>
    </ref>
    <ref id="bib10">
      <label>10</label>
      <element-citation publication-type="journal" id="sref10">
        <person-group person-group-type="author">
          <name>
            <surname>Saint-André</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Reddy</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Bradner</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Models of human core transcriptional regulatory circuitries</article-title>
        <source>Genome Res.</source>
        <volume>26</volume>
        <year>2016</year>
        <fpage>385</fpage>
        <lpage>396</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.197590.115</pub-id>
        <pub-id pub-id-type="pmid">26843070</pub-id>
      </element-citation>
    </ref>
    <ref id="bib11">
      <label>11</label>
      <element-citation publication-type="journal" id="sref11">
        <person-group person-group-type="author">
          <name>
            <surname>Aldiri</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Hiler</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Valentine</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Shirinifard</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Thiagarajan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sablauer</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
          <collab>St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project</collab>
        </person-group>
        <article-title>The dynamic epigenetic landscape of the retina during development, reprogramming, and tumorigenesis</article-title>
        <source>Neuron</source>
        <volume>94</volume>
        <year>2017</year>
        <fpage>550</fpage>
        <lpage>568.e10</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.022</pub-id>
        <pub-id pub-id-type="pmid">28472656</pub-id>
      </element-citation>
    </ref>
    <ref id="bib12">
      <label>12</label>
      <element-citation publication-type="journal" id="sref12">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Erkek</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Zapatka</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Haldipur</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kawauchi</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Risch</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Warnatz</surname>
            <given-names>H.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Active medulloblastoma enhancers reveal subgroup-specific cellular origins</article-title>
        <source>Nature</source>
        <volume>530</volume>
        <year>2016</year>
        <fpage>57</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1038/nature16546</pub-id>
        <pub-id pub-id-type="pmid">26814967</pub-id>
      </element-citation>
    </ref>
    <ref id="bib13">
      <label>13</label>
      <element-citation publication-type="journal" id="sref13">
        <person-group person-group-type="author">
          <name>
            <surname>Grandi</surname>
            <given-names>F.C.</given-names>
          </name>
          <name>
            <surname>Modi</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Kampman</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Corces</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Chromatin accessibility profiling by ATAC-seq</article-title>
        <source>Nat. Protoc.</source>
        <volume>17</volume>
        <year>2022</year>
        <fpage>1518</fpage>
        <lpage>1552</lpage>
        <pub-id pub-id-type="doi">10.1038/s41596-022-00692-9</pub-id>
        <pub-id pub-id-type="pmid">35478247</pub-id>
      </element-citation>
    </ref>
    <ref id="bib14">
      <label>14</label>
      <element-citation publication-type="journal" id="sref14">
        <person-group person-group-type="author">
          <name>
            <surname>Barrett</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Troup</surname>
            <given-names>D.B.</given-names>
          </name>
          <name>
            <surname>Wilhite</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Ledoux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Evangelista</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>I.F.</given-names>
          </name>
          <name>
            <surname>Tomashevsky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Phillippy</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>P.M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NCBI GEO: archive for functional genomics data sets--10 years on</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>39</volume>
        <year>2011</year>
        <fpage>D1005</fpage>
        <lpage>D1010</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1184</pub-id>
        <pub-id pub-id-type="pmid">21097893</pub-id>
      </element-citation>
    </ref>
    <ref id="bib15">
      <label>15</label>
      <element-citation publication-type="journal" id="sref15">
        <person-group person-group-type="author">
          <collab>ENCODE Project Consortium</collab>
        </person-group>
        <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
        <source>Nature</source>
        <volume>489</volume>
        <year>2012</year>
        <fpage>57</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
        <pub-id pub-id-type="pmid">22955616</pub-id>
      </element-citation>
    </ref>
    <ref id="bib16">
      <label>16</label>
      <element-citation publication-type="journal" id="sref16">
        <person-group person-group-type="author">
          <collab>Roadmap Epigenomics Consortium</collab>
          <name>
            <surname>Kundaje</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Meuleman</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Ernst</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bilenky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Heravi-Moussavi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kheradpour</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative analysis of 111 reference human epigenomes</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>317</fpage>
        <lpage>330</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14248</pub-id>
        <pub-id pub-id-type="pmid">25693563</pub-id>
      </element-citation>
    </ref>
    <ref id="bib17">
      <label>17</label>
      <element-citation publication-type="journal" id="sref17">
        <person-group person-group-type="author">
          <name>
            <surname>Bièche</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Lerebours</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Tozlu</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Espie</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Marty</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lidereau</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature</article-title>
        <source>Clin. Cancer Res.</source>
        <volume>10</volume>
        <year>2004</year>
        <fpage>6789</fpage>
        <lpage>6795</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0306</pub-id>
        <pub-id pub-id-type="pmid">15501955</pub-id>
      </element-citation>
    </ref>
    <ref id="bib18">
      <label>18</label>
      <element-citation publication-type="journal" id="sref18">
        <person-group person-group-type="author">
          <name>
            <surname>Jennings</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Quinn</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Rehman</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Orthopaedic surgery resident financial literacy: an assessment of knowledge in debt, investment, and retirement savings</article-title>
        <source>Am. Surg.</source>
        <volume>85</volume>
        <year>2019</year>
        <fpage>353</fpage>
        <lpage>358</lpage>
        <pub-id pub-id-type="pmid">31043194</pub-id>
      </element-citation>
    </ref>
    <ref id="bib19">
      <label>19</label>
      <element-citation publication-type="journal" id="sref19">
        <person-group person-group-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xi</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>High expression of kruppel-like factor 7 indicates unfavorable clinical outcomes in patients with lung adenocarcinoma</article-title>
        <source>J. Surg. Res.</source>
        <volume>250</volume>
        <year>2020</year>
        <fpage>216</fpage>
        <lpage>223</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jss.2019.12.053</pub-id>
        <pub-id pub-id-type="pmid">32092599</pub-id>
      </element-citation>
    </ref>
    <ref id="bib20">
      <label>20</label>
      <element-citation publication-type="journal" id="sref20">
        <person-group person-group-type="author">
          <name>
            <surname>Xiang</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>C.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis</article-title>
        <source>Theranostics</source>
        <volume>9</volume>
        <year>2019</year>
        <fpage>8182</fpage>
        <lpage>8195</lpage>
        <pub-id pub-id-type="doi">10.7150/thno.34983</pub-id>
        <pub-id pub-id-type="pmid">31754389</pub-id>
      </element-citation>
    </ref>
    <ref id="bib21">
      <label>21</label>
      <element-citation publication-type="journal" id="sref21">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S.H.</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>H.I.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Binas</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>K.S.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>Y.S.</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>Y.G.</given-names>
          </name>
        </person-group>
        <article-title>Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells</article-title>
        <source>J. Biol. Chem.</source>
        <volume>294</volume>
        <year>2019</year>
        <fpage>8424</fpage>
        <lpage>8437</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.RA119.008673</pub-id>
        <pub-id pub-id-type="pmid">30944148</pub-id>
      </element-citation>
    </ref>
    <ref id="bib22">
      <label>22</label>
      <element-citation publication-type="journal" id="sref22">
        <person-group person-group-type="author">
          <name>
            <surname>Ferrari</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Mohammed</surname>
            <given-names>Z.M.A.</given-names>
          </name>
          <name>
            <surname>Nixon</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Mallon</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>McMillan</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>E.R.</given-names>
          </name>
          <name>
            <surname>Edwards</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Blyth</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer</article-title>
        <source>PLoS One</source>
        <volume>9</volume>
        <year>2014</year>
        <fpage>e100759</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0100759</pub-id>
        <pub-id pub-id-type="pmid">24967588</pub-id>
      </element-citation>
    </ref>
    <ref id="bib23">
      <label>23</label>
      <element-citation publication-type="journal" id="sref23">
        <person-group person-group-type="author">
          <name>
            <surname>Godini</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Fallahi</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Dynamics changes in the transcription factors during early human embryonic development</article-title>
        <source>J. Cell. Physiol.</source>
        <volume>234</volume>
        <year>2019</year>
        <fpage>6489</fpage>
        <lpage>6502</lpage>
        <pub-id pub-id-type="doi">10.1002/jcp.27386</pub-id>
        <pub-id pub-id-type="pmid">30246428</pub-id>
      </element-citation>
    </ref>
    <ref id="bib24">
      <label>24</label>
      <element-citation publication-type="journal" id="sref24">
        <person-group person-group-type="author">
          <name>
            <surname>Litvinov</surname>
            <given-names>I.V.</given-names>
          </name>
          <name>
            <surname>Vander Griend</surname>
            <given-names>D.J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Antony</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Dalrymple</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Isaacs</surname>
            <given-names>J.T.</given-names>
          </name>
        </person-group>
        <article-title>Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells</article-title>
        <source>Cancer Res.</source>
        <volume>66</volume>
        <year>2006</year>
        <fpage>8598</fpage>
        <lpage>8607</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-1228</pub-id>
        <pub-id pub-id-type="pmid">16951173</pub-id>
      </element-citation>
    </ref>
    <ref id="bib25">
      <label>25</label>
      <element-citation publication-type="journal" id="sref25">
        <person-group person-group-type="author">
          <name>
            <surname>Neou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Villa</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Armignacco</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jouinot</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Raffin-Sanson</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Septier</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Letourneur</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Diry</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Diedisheim</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Izac</surname>
            <given-names>B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pangenomic classification of pituitary neuroendocrine tumors</article-title>
        <source>Cancer Cell</source>
        <volume>37</volume>
        <year>2020</year>
        <fpage>123</fpage>
        <lpage>134.e5</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2019.11.002</pub-id>
        <pub-id pub-id-type="pmid">31883967</pub-id>
      </element-citation>
    </ref>
    <ref id="bib26">
      <label>26</label>
      <element-citation publication-type="journal" id="sref26">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Shox2 regulates osteogenic differentiation and pattern formation during hard palate development in mice</article-title>
        <source>J. Biol. Chem.</source>
        <volume>294</volume>
        <year>2019</year>
        <fpage>18294</fpage>
        <lpage>18305</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.RA119.008801</pub-id>
        <pub-id pub-id-type="pmid">31649032</pub-id>
      </element-citation>
    </ref>
    <ref id="bib27">
      <label>27</label>
      <element-citation publication-type="journal" id="sref27">
        <person-group person-group-type="author">
          <name>
            <surname>Clarke</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ballios</surname>
            <given-names>B.G.</given-names>
          </name>
          <name>
            <surname>van der Kooy</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Generation and clonal isolation of retinal stem cells from human embryonic stem cells</article-title>
        <source>Eur. J. Neurosci.</source>
        <volume>36</volume>
        <year>2012</year>
        <fpage>1951</fpage>
        <lpage>1959</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08123.x</pub-id>
        <pub-id pub-id-type="pmid">22591375</pub-id>
      </element-citation>
    </ref>
    <ref id="bib28">
      <label>28</label>
      <element-citation publication-type="journal" id="sref28">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Ai</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TF-Marker: a comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>50</volume>
        <year>2022</year>
        <fpage>D402</fpage>
        <lpage>D412</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab1114</pub-id>
        <pub-id pub-id-type="pmid">34986601</pub-id>
      </element-citation>
    </ref>
    <ref id="bib29">
      <label>29</label>
      <element-citation publication-type="journal" id="sref29">
        <person-group person-group-type="author">
          <name>
            <surname>Hnisz</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Saint-André</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Sigova</surname>
            <given-names>A.A.</given-names>
          </name>
          <name>
            <surname>Hoke</surname>
            <given-names>H.A.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Super-enhancers in the control of cell identity and disease</article-title>
        <source>Cell</source>
        <volume>155</volume>
        <year>2013</year>
        <fpage>934</fpage>
        <lpage>947</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.053</pub-id>
        <pub-id pub-id-type="pmid">24119843</pub-id>
      </element-citation>
    </ref>
    <ref id="bib30">
      <label>30</label>
      <element-citation publication-type="journal" id="sref30">
        <person-group person-group-type="author">
          <collab>GTEx Consortium</collab>
        </person-group>
        <article-title>The genotype-tissue expression (GTEx) project</article-title>
        <source>Nat. Genet.</source>
        <volume>45</volume>
        <year>2013</year>
        <fpage>580</fpage>
        <lpage>585</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2653</pub-id>
        <pub-id pub-id-type="pmid">23715323</pub-id>
      </element-citation>
    </ref>
    <ref id="bib31">
      <label>31</label>
      <element-citation publication-type="journal" id="sref31">
        <person-group person-group-type="author">
          <name>
            <surname>Ajayi-Smith</surname>
            <given-names>A.F.</given-names>
          </name>
          <name>
            <surname>van der Watt</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Leaner</surname>
            <given-names>V.D.</given-names>
          </name>
        </person-group>
        <article-title>Interfering with nuclear transport as a means of interrupting transcription factor activity in cancer</article-title>
        <source>Crit. Rev. Eukaryot. Gene Expr.</source>
        <volume>29</volume>
        <year>2019</year>
        <fpage>413</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.1615/CritRevEukaryotGeneExpr.2019026309</pub-id>
        <pub-id pub-id-type="pmid">32421998</pub-id>
      </element-citation>
    </ref>
    <ref id="bib32">
      <label>32</label>
      <element-citation publication-type="journal" id="sref32">
        <person-group person-group-type="author">
          <name>
            <surname>Nimura</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Takeichi</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Saga</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Takaoka</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kawamura</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Nitta</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Nagano</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Ishino</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>T.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development</article-title>
        <source>Elife</source>
        <volume>5</volume>
        <year>2016</year>
        <fpage>e16030</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.16030</pub-id>
        <pub-id pub-id-type="pmid">27331609</pub-id>
      </element-citation>
    </ref>
    <ref id="bib33">
      <label>33</label>
      <element-citation publication-type="journal" id="sref33">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B.Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>The role of Tbx20 in cardiovascular development and function</article-title>
        <source>Front. Cell Dev. Biol.</source>
        <volume>9</volume>
        <year>2021</year>
        <fpage>638542</fpage>
        <pub-id pub-id-type="doi">10.3389/fcell.2021.638542</pub-id>
        <pub-id pub-id-type="pmid">33585493</pub-id>
      </element-citation>
    </ref>
    <ref id="bib34">
      <label>34</label>
      <element-citation publication-type="journal" id="sref34">
        <person-group person-group-type="author">
          <name>
            <surname>Butler</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Centenera</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Swinnen</surname>
            <given-names>J.V.</given-names>
          </name>
        </person-group>
        <article-title>Androgen control of lipid metabolism in prostate cancer: novel insights and future applications</article-title>
        <source>Endocr. Relat. Cancer</source>
        <volume>23</volume>
        <year>2016</year>
        <fpage>R219</fpage>
        <lpage>R227</lpage>
        <pub-id pub-id-type="doi">10.1530/ERC-15-0556</pub-id>
        <pub-id pub-id-type="pmid">27130044</pub-id>
      </element-citation>
    </ref>
    <ref id="bib35">
      <label>35</label>
      <element-citation publication-type="journal" id="sref35">
        <person-group person-group-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Flohr</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Shipley</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Giddings</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Te-Poele</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Dodson</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Foster</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jhavar</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer</article-title>
        <source>Br. J. Cancer</source>
        <volume>92</volume>
        <year>2005</year>
        <fpage>376</fpage>
        <lpage>381</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.bjc.6602261</pub-id>
        <pub-id pub-id-type="pmid">15583692</pub-id>
      </element-citation>
    </ref>
    <ref id="bib36">
      <label>36</label>
      <element-citation publication-type="journal" id="sref36">
        <person-group person-group-type="author">
          <name>
            <surname>Economides</surname>
            <given-names>K.D.</given-names>
          </name>
          <name>
            <surname>Capecchi</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Hoxb13 is required for normal differentiation and secretory function of the ventral prostate</article-title>
        <source>Development</source>
        <volume>130</volume>
        <year>2003</year>
        <fpage>2061</fpage>
        <lpage>2069</lpage>
        <pub-id pub-id-type="doi">10.1242/dev.00432</pub-id>
        <pub-id pub-id-type="pmid">12668621</pub-id>
      </element-citation>
    </ref>
    <ref id="bib37">
      <label>37</label>
      <element-citation publication-type="journal" id="sref37">
        <person-group person-group-type="author">
          <name>
            <surname>Thiele</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Varus</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Wickenhauser</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kvasnicka</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Metz</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Beelen</surname>
            <given-names>D.W.</given-names>
          </name>
        </person-group>
        <article-title>Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation</article-title>
        <source>Histol. Histopathol.</source>
        <volume>19</volume>
        <year>2004</year>
        <fpage>201</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="doi">10.14670/HH-19.201</pub-id>
        <pub-id pub-id-type="pmid">14702188</pub-id>
      </element-citation>
    </ref>
    <ref id="bib38">
      <label>38</label>
      <element-citation publication-type="journal" id="sref38">
        <person-group person-group-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Bristor</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Hiller</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Schaar</surname>
            <given-names>B.T.</given-names>
          </name>
          <name>
            <surname>Lowe</surname>
            <given-names>C.B.</given-names>
          </name>
          <name>
            <surname>Wenger</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Bejerano</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title>
        <source>Nat. Biotechnol.</source>
        <volume>28</volume>
        <year>2010</year>
        <fpage>495</fpage>
        <lpage>501</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.1630</pub-id>
        <pub-id pub-id-type="pmid">20436461</pub-id>
      </element-citation>
    </ref>
    <ref id="bib39">
      <label>39</label>
      <element-citation publication-type="journal" id="sref39">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy</article-title>
        <source>EBioMedicine</source>
        <volume>83</volume>
        <year>2022</year>
        <fpage>104207</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104207</pub-id>
        <pub-id pub-id-type="pmid">35961204</pub-id>
      </element-citation>
    </ref>
    <ref id="bib40">
      <label>40</label>
      <element-citation publication-type="journal" id="sref40">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy</article-title>
        <source>Br. J. Cancer</source>
        <volume>126</volume>
        <year>2022</year>
        <fpage>1570</fpage>
        <lpage>1580</lpage>
        <pub-id pub-id-type="doi">10.1038/s41416-021-01692-4</pub-id>
        <pub-id pub-id-type="pmid">35017656</pub-id>
      </element-citation>
    </ref>
    <ref id="bib41">
      <label>41</label>
      <element-citation publication-type="journal" id="sref41">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer</article-title>
        <source>J. Immunother. Cancer</source>
        <volume>8</volume>
        <year>2020</year>
        <fpage>e000110</fpage>
        <pub-id pub-id-type="doi">10.1136/jitc-2019-000110</pub-id>
        <pub-id pub-id-type="pmid">32041817</pub-id>
      </element-citation>
    </ref>
    <ref id="bib42">
      <label>42</label>
      <element-citation publication-type="journal" id="sref42">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer</article-title>
        <source>Brief. Bioinform.</source>
        <volume>22</volume>
        <year>2021</year>
        <fpage>bbaa047</fpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbaa047</pub-id>
        <pub-id pub-id-type="pmid">32382761</pub-id>
      </element-citation>
    </ref>
    <ref id="bib43">
      <label>43</label>
      <element-citation publication-type="journal" id="sref43">
        <person-group person-group-type="author">
          <name>
            <surname>Cha</surname>
            <given-names>H.R.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J.H.</given-names>
          </name>
          <name>
            <surname>Ponnazhagan</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Revisiting immunotherapy: a focus on prostate cancer</article-title>
        <source>Cancer Res.</source>
        <volume>80</volume>
        <year>2020</year>
        <fpage>1615</fpage>
        <lpage>1623</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-2948</pub-id>
        <pub-id pub-id-type="pmid">32066566</pub-id>
      </element-citation>
    </ref>
    <ref id="bib44">
      <label>44</label>
      <element-citation publication-type="journal" id="sref44">
        <person-group person-group-type="author">
          <name>
            <surname>Guan</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Polesso</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Sehrawat</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hawkins</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>G.V.</given-names>
          </name>
          <name>
            <surname>Caruso</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>R.F.</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>M.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Androgen receptor activity in T cells limits checkpoint blockade efficacy</article-title>
        <source>Nature</source>
        <volume>606</volume>
        <year>2022</year>
        <fpage>791</fpage>
        <lpage>796</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-022-04522-6</pub-id>
        <pub-id pub-id-type="pmid">35322234</pub-id>
      </element-citation>
    </ref>
    <ref id="bib45">
      <label>45</label>
      <element-citation publication-type="journal" id="sref45">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity</article-title>
        <source>Immunity</source>
        <volume>55</volume>
        <year>2022</year>
        <fpage>1268</fpage>
        <lpage>1283.e9</lpage>
        <pub-id pub-id-type="doi">10.1016/j.immuni.2022.05.012</pub-id>
        <pub-id pub-id-type="pmid">35700739</pub-id>
      </element-citation>
    </ref>
    <ref id="bib46">
      <label>46</label>
      <element-citation publication-type="journal" id="sref46">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>X.H.</given-names>
          </name>
          <name>
            <surname>Black</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Ustiyan</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fulford</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sridharan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Medvedovic</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kalinichenko</surname>
            <given-names>V.V.</given-names>
          </name>
          <name>
            <surname>Whitsett</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Kalin</surname>
            <given-names>T.V.</given-names>
          </name>
        </person-group>
        <article-title>SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene</article-title>
        <source>PLoS Genet.</source>
        <volume>10</volume>
        <year>2014</year>
        <fpage>e1004656</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004656</pub-id>
        <pub-id pub-id-type="pmid">25254494</pub-id>
      </element-citation>
    </ref>
    <ref id="bib47">
      <label>47</label>
      <element-citation publication-type="journal" id="sref47">
        <person-group person-group-type="author">
          <name>
            <surname>Korfhagen</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Kitzmiller</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Sridharan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Haitchi</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Hegde</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Divanovic</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Karp</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Whitsett</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <volume>109</volume>
        <year>2012</year>
        <fpage>16630</fpage>
        <lpage>16635</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1208092109</pub-id>
        <pub-id pub-id-type="pmid">23012424</pub-id>
      </element-citation>
    </ref>
    <ref id="bib48">
      <label>48</label>
      <element-citation publication-type="journal" id="sref48">
        <person-group person-group-type="author">
          <name>
            <surname>Riazi</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Van Arsdell</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>CSX/Nkx2.5 modulates differentiation of skeletal myoblasts and promotes differentiation into neuronal cells in vitro</article-title>
        <source>J. Biol. Chem.</source>
        <volume>280</volume>
        <year>2005</year>
        <fpage>10716</fpage>
        <lpage>10720</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M500028200</pub-id>
        <pub-id pub-id-type="pmid">15653675</pub-id>
      </element-citation>
    </ref>
    <ref id="bib49">
      <label>49</label>
      <element-citation publication-type="journal" id="sref49">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Santostefano</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Terada</surname>
            <given-names>N.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery</article-title>
        <source>PLoS One</source>
        <volume>13</volume>
        <year>2018</year>
        <fpage>e0194895</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0194895</pub-id>
        <pub-id pub-id-type="pmid">29579079</pub-id>
      </element-citation>
    </ref>
    <ref id="bib50">
      <label>50</label>
      <element-citation publication-type="journal" id="sref50">
        <person-group person-group-type="author">
          <name>
            <surname>Vincentz</surname>
            <given-names>J.W.</given-names>
          </name>
          <name>
            <surname>Barnes</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Firulli</surname>
            <given-names>B.A.</given-names>
          </name>
          <name>
            <surname>Conway</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Firulli</surname>
            <given-names>A.B.</given-names>
          </name>
        </person-group>
        <article-title>Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart development</article-title>
        <source>Dev. Dyn.</source>
        <volume>237</volume>
        <year>2008</year>
        <fpage>3809</fpage>
        <lpage>3819</lpage>
        <pub-id pub-id-type="doi">10.1002/dvdy.21803</pub-id>
        <pub-id pub-id-type="pmid">19035347</pub-id>
      </element-citation>
    </ref>
    <ref id="bib51">
      <label>51</label>
      <element-citation publication-type="journal" id="sref51">
        <person-group person-group-type="author">
          <name>
            <surname>Ziller</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Edri</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Yaffe</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Donaghey</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pop</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Mallard</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Issner</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Goren</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dissecting neural differentiation regulatory networks through epigenetic footprinting</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>355</fpage>
        <lpage>359</lpage>
        <pub-id pub-id-type="doi">10.1038/nature13990</pub-id>
        <pub-id pub-id-type="pmid">25533951</pub-id>
      </element-citation>
    </ref>
    <ref id="bib52">
      <label>52</label>
      <element-citation publication-type="journal" id="sref52">
        <person-group person-group-type="author">
          <name>
            <surname>Dixon</surname>
            <given-names>J.R.</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Selvaraj</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Antosiewicz-Bourget</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A.Y.</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Rajagopal</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>W.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Chromatin architecture reorganization during stem cell differentiation</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>331</fpage>
        <lpage>336</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14222</pub-id>
        <pub-id pub-id-type="pmid">25693564</pub-id>
      </element-citation>
    </ref>
    <ref id="bib53">
      <label>53</label>
      <element-citation publication-type="journal" id="sref53">
        <person-group person-group-type="author">
          <name>
            <surname>Tsankov</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Akopian</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Ziller</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Donaghey</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Amit</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Gnirke</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Meissner</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Transcription factor binding dynamics during human ES cell differentiation</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>344</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14233</pub-id>
        <pub-id pub-id-type="pmid">25693565</pub-id>
      </element-citation>
    </ref>
    <ref id="bib54">
      <label>54</label>
      <element-citation publication-type="journal" id="sref54">
        <person-group person-group-type="author">
          <name>
            <surname>Neph</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Stergachis</surname>
            <given-names>A.B.</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Borenstein</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Stamatoyannopoulos</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Circuitry and dynamics of human transcription factor regulatory networks</article-title>
        <source>Cell</source>
        <volume>150</volume>
        <year>2012</year>
        <fpage>1274</fpage>
        <lpage>1286</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.04.040</pub-id>
        <pub-id pub-id-type="pmid">22959076</pub-id>
      </element-citation>
    </ref>
    <ref id="bib55">
      <label>55</label>
      <element-citation publication-type="journal" id="sref55">
        <person-group person-group-type="author">
          <name>
            <surname>Novershtern</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Lawton</surname>
            <given-names>L.N.</given-names>
          </name>
          <name>
            <surname>Mak</surname>
            <given-names>R.H.</given-names>
          </name>
          <name>
            <surname>Haining</surname>
            <given-names>W.N.</given-names>
          </name>
          <name>
            <surname>McConkey</surname>
            <given-names>M.E.</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Yosef</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Shay</surname>
            <given-names>T.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Densely interconnected transcriptional circuits control cell states in human hematopoiesis</article-title>
        <source>Cell</source>
        <volume>144</volume>
        <year>2011</year>
        <fpage>296</fpage>
        <lpage>309</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2011.01.004</pub-id>
        <pub-id pub-id-type="pmid">21241896</pub-id>
      </element-citation>
    </ref>
    <ref id="bib56">
      <label>56</label>
      <element-citation publication-type="journal" id="sref56">
        <person-group person-group-type="author">
          <name>
            <surname>Huynh-Thu</surname>
            <given-names>V.A.</given-names>
          </name>
          <name>
            <surname>Irrthum</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Wehenkel</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Geurts</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Inferring regulatory networks from expression data using tree-based methods</article-title>
        <source>PLoS One</source>
        <volume>5</volume>
        <year>2010</year>
        <fpage>e12776</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0012776</pub-id>
        <pub-id pub-id-type="pmid">20927193</pub-id>
      </element-citation>
    </ref>
    <ref id="bib57">
      <label>57</label>
      <element-citation publication-type="journal" id="sref57">
        <person-group person-group-type="author">
          <name>
            <surname>Margolin</surname>
            <given-names>A.A.</given-names>
          </name>
          <name>
            <surname>Nemenman</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Basso</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Wiggins</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Stolovitzky</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Dalla Favera</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Califano</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>
        <source>BMC Bioinformatics</source>
        <volume>7</volume>
        <year>2006</year>
        <fpage>S7</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-7-S1-S7</pub-id>
      </element-citation>
    </ref>
    <ref id="bib58">
      <label>58</label>
      <element-citation publication-type="journal" id="sref58">
        <person-group person-group-type="author">
          <name>
            <surname>Lovén</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Hoke</surname>
            <given-names>H.A.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Orlando</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Vakoc</surname>
            <given-names>C.R.</given-names>
          </name>
          <name>
            <surname>Bradner</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Selective inhibition of tumor oncogenes by disruption of super-enhancers</article-title>
        <source>Cell</source>
        <volume>153</volume>
        <year>2013</year>
        <fpage>320</fpage>
        <lpage>334</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.03.036</pub-id>
        <pub-id pub-id-type="pmid">23582323</pub-id>
      </element-citation>
    </ref>
    <ref id="bib59">
      <label>59</label>
      <element-citation publication-type="journal" id="sref59">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Eeckhoute</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D.S.</given-names>
          </name>
          <name>
            <surname>Bernstein</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Nusbaum</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.S.</given-names>
          </name>
        </person-group>
        <article-title>Model-based analysis of ChIP-seq (MACS)</article-title>
        <source>Genome Biol.</source>
        <volume>9</volume>
        <year>2008</year>
        <fpage>R137</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id>
        <pub-id pub-id-type="pmid">18798982</pub-id>
      </element-citation>
    </ref>
    <ref id="bib60">
      <label>60</label>
      <element-citation publication-type="journal" id="sref60">
        <person-group person-group-type="author">
          <name>
            <surname>Matys</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Kel-Margoulis</surname>
            <given-names>O.V.</given-names>
          </name>
          <name>
            <surname>Fricke</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Liebich</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Land</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Barre-Dirrie</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Reuter</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Chekmenev</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Krull</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hornischer</surname>
            <given-names>K.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>34</volume>
        <year>2006</year>
        <fpage>D108</fpage>
        <lpage>D110</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkj143</pub-id>
        <pub-id pub-id-type="pmid">16381825</pub-id>
      </element-citation>
    </ref>
    <ref id="bib61">
      <label>61</label>
      <element-citation publication-type="journal" id="sref61">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Fornes</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Stigliani</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Gheorghe</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Castro-Mondragon</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>van der Lee</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Bessy</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chèneby</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kulkarni</surname>
            <given-names>S.R.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>46</volume>
        <year>2018</year>
        <fpage>D260</fpage>
        <lpage>D266</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1126</pub-id>
        <pub-id pub-id-type="pmid">29140473</pub-id>
      </element-citation>
    </ref>
    <ref id="bib62">
      <label>62</label>
      <element-citation publication-type="journal" id="sref62">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>T.L.</given-names>
          </name>
          <name>
            <surname>Boden</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Buske</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Frith</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>C.E.</given-names>
          </name>
          <name>
            <surname>Clementi</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.W.</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>W.S.</given-names>
          </name>
        </person-group>
        <article-title>MEME SUITE: tools for motif discovery and searching</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>37</volume>
        <year>2009</year>
        <fpage>W202</fpage>
        <lpage>W208</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id>
        <pub-id pub-id-type="pmid">19458158</pub-id>
      </element-citation>
    </ref>
    <ref id="bib63">
      <label>63</label>
      <element-citation publication-type="journal" id="sref63">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bravo</surname>
            <given-names>À.</given-names>
          </name>
          <name>
            <surname>Queralt-Rosinach</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Gutiérrez-Sacristán</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Deu-Pons</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Centeno</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>García-García</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sanz</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Furlong</surname>
            <given-names>L.I.</given-names>
          </name>
        </person-group>
        <article-title>DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>45</volume>
        <year>2017</year>
        <fpage>D833</fpage>
        <lpage>D839</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw943</pub-id>
        <pub-id pub-id-type="pmid">27924018</pub-id>
      </element-citation>
    </ref>
    <ref id="bib64">
      <label>64</label>
      <element-citation publication-type="journal" id="sref64">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Q.Y.</given-names>
          </name>
        </person-group>
        <article-title>ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title>
        <source>Bioinformatics</source>
        <volume>31</volume>
        <year>2015</year>
        <fpage>2382</fpage>
        <lpage>2383</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv145</pub-id>
        <pub-id pub-id-type="pmid">25765347</pub-id>
      </element-citation>
    </ref>
    <ref id="bib65">
      <label>65</label>
      <element-citation publication-type="journal" id="sref65">
        <person-group person-group-type="author">
          <name>
            <surname>Adamcsek</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Palla</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Farkas</surname>
            <given-names>I.J.</given-names>
          </name>
          <name>
            <surname>Derényi</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Vicsek</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>CFinder: locating cliques and overlapping modules in biological networks</article-title>
        <source>Bioinformatics</source>
        <volume>22</volume>
        <year>2006</year>
        <fpage>1021</fpage>
        <lpage>1023</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl039</pub-id>
        <pub-id pub-id-type="pmid">16473872</pub-id>
      </element-citation>
    </ref>
    <ref id="bib66">
      <label>66</label>
      <element-citation publication-type="journal" id="sref66">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Q.Y.</given-names>
          </name>
        </person-group>
        <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
        <source>OMICS</source>
        <volume>16</volume>
        <year>2012</year>
        <fpage>284</fpage>
        <lpage>287</lpage>
        <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
        <pub-id pub-id-type="pmid">22455463</pub-id>
      </element-citation>
    </ref>
    <ref id="bib67">
      <label>67</label>
      <element-citation publication-type="journal" id="sref67">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.S.</given-names>
          </name>
        </person-group>
        <article-title>TIMER2.0 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2020</year>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="appsec2" sec-type="supplementary-material">
    <title>Supplemental information</title>
    <p id="p0235">
      <supplementary-material content-type="local-data" id="mmc1">
        <caption>
          <title>Document S1. Figures S1 and S2</title>
        </caption>
        <media xlink:href="mmc1.pdf"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc2">
        <caption>
          <title>Table S1. All the samples of CRCs in more than 50 cell/tissue types</title>
        </caption>
        <media xlink:href="mmc2.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc3">
        <caption>
          <title>Table S2. The specific and overlapped core TFs identified by using <italic>Coltron</italic> and <italic>CRC mapper</italic> across 22 major tissues</title>
        </caption>
        <media xlink:href="mmc3.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc4">
        <caption>
          <title>Table S3. All CRC networks identified by <italic>Coltron</italic></title>
        </caption>
        <media xlink:href="mmc4.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc5">
        <caption>
          <title>Table S4. All CRC networks identified by <italic>CRC mapper</italic></title>
        </caption>
        <media xlink:href="mmc5.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc6">
        <caption>
          <title>Document S2. Article plus supplemental information</title>
        </caption>
        <media xlink:href="mmc6.pdf"/>
      </supplementary-material>
    </p>
  </sec>
  <ack id="ack0010">
    <title>Acknowledgments</title>
    <p id="p0215">This work was supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> (62001145, 62171166, and 62272212), the <funding-source id="gs2">Natural Science Foundation for Distinguished Young Scholars</funding-source> of Heilongjiang Province of China (JQ2020C004), the Research Foundation of the <funding-source id="gs3">First Affiliated Hospital of University of South China</funding-source> for Advanced Talents (20210002-1005 USCAT-2021-01), Wu Liande Youth Science Research Fund of <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100010722</institution-id><institution>Harbin Medical University</institution></institution-wrap></funding-source> (Daqing) (JFWLD202001), and the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source> (2019M661311).</p>
    <sec id="sec5">
      <title>Author contributions</title>
      <p id="p0220">C.L., C.S., and C.F. designed the subject, wrote and revised the manuscript. Y.J. and Y.W. built the database. J. Zhang, J. Zhao, and M.Y. finished the figures. J. Zhu, B.A., and Q.W. conducted the experiments. F.Q., Y.Z., D.S., and J.L. processed the data.</p>
    </sec>
    <sec sec-type="COI-statement" id="sec6">
      <title>Declaration of interests</title>
      <p id="p0225">The authors declare no competing interests.</p>
    </sec>
  </ack>
  <fn-group>
    <fn id="appsec1" fn-type="supplementary-material">
      <p id="p0230">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.omtn.2023.03.014" id="intref0045">https://doi.org/10.1016/j.omtn.2023.03.014</ext-link>.</p>
    </fn>
  </fn-group>
</back>
<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_OMTN1870 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEgr5 jpg ?>
<?FILEgr6 jpg ?>
<?FILEgr7 jpg ?>
<?FILEfx1 jpg ?>
<?FILEmmc1 pdf ?>
<?FILEmmc2 xls ?>
<?FILEmmc3 xls ?>
<?FILEmmc4 xls ?>
<?FILEmmc5 xls ?>
<?FILEmmc6 pdf ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Mol Ther Nucleic Acids</journal-id>
    <journal-id journal-id-type="iso-abbrev">Mol Ther Nucleic Acids</journal-id>
    <journal-title-group>
      <journal-title>Molecular Therapy. Nucleic Acids</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2162-2531</issn>
    <publisher>
      <publisher-name>American Society of Gene &amp; Cell Therapy</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10149290</article-id>
    <article-id pub-id-type="pii">S2162-2531(23)00073-2</article-id>
    <article-id pub-id-type="doi">10.1016/j.omtn.2023.03.014</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Landscape and significance of human super enhancer-driven core transcription regulatory circuitry</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au1">
        <name>
          <surname>Feng</surname>
          <given-names>Chenchen</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au2">
        <name>
          <surname>Song</surname>
          <given-names>Chao</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au3">
        <name>
          <surname>Jiang</surname>
          <given-names>Yong</given-names>
        </name>
        <xref rid="aff8" ref-type="aff">8</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au4">
        <name>
          <surname>Zhao</surname>
          <given-names>Jun</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="fn1" ref-type="fn">9</xref>
      </contrib>
      <contrib contrib-type="author" id="au5">
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au6">
        <name>
          <surname>Wang</surname>
          <given-names>Yuezhu</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au7">
        <name>
          <surname>Yin</surname>
          <given-names>Mingxue</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au8">
        <name>
          <surname>Zhu</surname>
          <given-names>Jiang</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au9">
        <name>
          <surname>Ai</surname>
          <given-names>Bo</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
      </contrib>
      <contrib contrib-type="author" id="au10">
        <name>
          <surname>Wang</surname>
          <given-names>Qiuyu</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
      </contrib>
      <contrib contrib-type="author" id="au11">
        <name>
          <surname>Qian</surname>
          <given-names>Fengcui</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au12">
        <name>
          <surname>Zhang</surname>
          <given-names>Yuexin</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au13">
        <name>
          <surname>Shang</surname>
          <given-names>Desi</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
      </contrib>
      <contrib contrib-type="author" id="au14">
        <name>
          <surname>Liu</surname>
          <given-names>Jiaqi</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au15">
        <name>
          <surname>Li</surname>
          <given-names>Chunquan</given-names>
        </name>
        <email>lcqbio@163.com</email>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
        <xref rid="aff4" ref-type="aff">4</xref>
        <xref rid="aff5" ref-type="aff">5</xref>
        <xref rid="aff6" ref-type="aff">6</xref>
        <xref rid="aff7" ref-type="aff">7</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <aff id="aff1"><label>1</label>School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China</aff>
      <aff id="aff2"><label>2</label>The First Affiliated Hospital, Institute of Cardiovascular Disease, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff3"><label>3</label>School of Computer, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff4"><label>4</label>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Affiliated Intelligence, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff5"><label>5</label>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff6"><label>6</label>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff7"><label>7</label>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China</aff>
      <aff id="aff8"><label>8</label>Medical Research Institute, Wuhan University, Wuhan 430000, China</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Corresponding author: Chunquan Li, School of Medical Informatics, Daqing Campus, Harbin Medical University, Daqing 163319, China. <email>lcqbio@163.com</email></corresp>
      <fn id="fn1">
        <label>9</label>
        <p id="ntpara0010">These authors contributed equally</p>
      </fn>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <day>13</day>
      <month>6</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>3</month>
      <year>2023</year>
    </pub-date>
    <volume>32</volume>
    <fpage>385</fpage>
    <lpage>401</lpage>
    <history>
      <date date-type="received">
        <day>3</day>
        <month>1</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>3</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder/>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract id="abs0010">
      <p>A core transcription regulatory circuitry (CRC) is an interconnected self-regulatory circuitry that is formed by a group of core transcription factors (TFs). These core TFs collectively regulate gene expression by binding not only to their own super enhancers (SEs) but also to the SEs of one another. For most human tissue/cell types, a global view of CRCs and core TFs has not been generated. Here, we identified numerous CRCs using two identification methods and detailed the landscape of the CRCs driven by SEs in large cell/tissue samples. The comprehensive biological analyses, including sequence conservation, CRC activity and genome binding affinity were conducted for common TFs, moderate TFs, and specific TFs, which exhibit different biological features. The local module located from the common CRC network highlighted the essential functions and prognostic performance. The tissue-specific CRC network was highly related to cell identity. Core TFs in tissue-specific CRC networks exhibited disease markers, and had regulatory potential for cancer immunotherapy. Moreover, a user-friendly resource named CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0010">http://www.licpathway.net/crcdb/index.html</ext-link>) was developed, which contained the detailed information of CRCs and core TFs used in this study, as well as other interesting results, such as the most representative CRC, frequency of TFs, and indegree/outdegree of TFs.</p>
    </abstract>
    <abstract abstract-type="graphical" id="abs0015">
      <title>Graphical abstract</title>
      <fig id="undfig1" position="anchor">
        <graphic xlink:href="fx1"/>
      </fig>
    </abstract>
    <abstract abstract-type="teaser" id="abs0020">
      <p>Li and colleagues describe numerous CRCs and provide comprehensive human CRC models in massive cell/tissue samples. Our work generates significant and extensive insights into the transcriptomic and epigenomic landscape of SE-driven CRCs and highlights the functional and regulatory roles of core TFs in maintaining cell identity and disease regulation.</p>
    </abstract>
    <kwd-group id="kwrds0010">
      <title>Keywords</title>
      <kwd>MT: Bioinformatics</kwd>
      <kwd>core transcription regulatory circuitry</kwd>
      <kwd>transcription factor</kwd>
      <kwd>super enhancer</kwd>
      <kwd>network analysis</kwd>
      <kwd>platform</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p id="p0010">Gene transcription is a complex cellular process involving a variety of enzymes and organelles. As <italic>trans</italic>-acting factors, transcription factors (TFs) are important components of regulatory gene transcription networks.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> TFs are often coupled with proteins to form regulatory complexes, which bind promoters or enhancers of genes, participate in gene transcription, and affect gene expression. Thus, TFs are an indispensable part of cellular activities.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> There are a small number of master TFs that dominate the control of gene expression programs governing cell state and cell identity in a cell-type-specific or lineage-specific manner.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Within a given cell type, some TFs work together to regulate their own genes, and many others. They bind to not only their own genes but also those of the other TFs, forming interconnected self-regulatory circuitry, termed core transcription regulatory circuitry (CRC).<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> TFs within the CRCs are considered as the core TFs for a specific cell type.</p>
    <p id="p0015">Core TFs enrich genes associated with a variety of diseases or traits and provide an effective means of discovering cellular identity genes and reprogramming genes.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> For example, the core TFs <italic>OCT4</italic>, <italic>SOX2</italic>, and <italic>NANOG</italic> collaborate to play essential roles in early cell development and contribute to the establishment and maintenance of embryonic stem cell identity.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> Genome-wide chromatin immunoprecipitation followed by sequencing (ChIP-seq) analyses demonstrated that a small number of core TFs, including <italic>MYCN</italic>, <italic>HAND2</italic>, <italic>ISL1</italic>, <italic>PHOX2B</italic>, <italic>GATA3</italic>, and <italic>TBX2</italic>, maintain cell state and survival in <italic>MYCN</italic>-amplified neuroblastomas.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Recent studies also showed that the core TFs forming CRCs play a crucial role in the development of cancer by binding to super enhancers (SEs) to activate the transcription of specific genes in cells.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> They bind not only to their own SEs but also to the SEs of each other. By analyzing 21 cases of rhabdomyosarcoma, Gryder et al. identified the core TFs <italic>SOX8</italic>, <italic>MYOD1</italic>, and <italic>MYOG</italic>.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> These TFs, which are regulated by highly acetylated SEs, bound not only to their own SEs but also to SEs associated with other important genes, thereby affecting the fate of the entire cell. Jiang et al. established a CRC model mediated by core TFs and SEs in esophageal squamous cell carcinoma (ESCC), and found the core TFs, <italic>TP63</italic>, <italic>SOX2</italic>, and <italic>KLF5</italic>, to be part of a CRC network that determined chromatin accessibility, epigenetic modifications, and gene expression patterns in ESCC cells.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> Collectively, CRCs provide a novel strategy to study the gene expression programs and transcription patterns that control cellular identity and to better understand transcriptional abnormalities in diseases. However, for most cell types, an understanding of the core TFs and CRCs is limited. The identification of CRCs in various cell/tissue types will be valuable for studies of transcriptional regulation of specific cell types in healthy and diseased states.</p>
    <p id="p0020">The classical <italic>CRC mapper</italic> algorithm was developed to identify CRC models of human cell types, in which core TFs are encoded by genes associated with SEs. SEs have high signal densities for H3K27ac and were identified from H3K27ac ChIP-seq data.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Aldiri et al. used <italic>CRC mapper</italic> to identify the dynamic CRC landscape of the retina during development, reprogramming, and tumorigenesis.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Lin et al. used <italic>CRC mapper</italic> to reconstruct CRCs to identify core TFs associated with subgroup divergence and subgroup-specific cellular origins.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> The assay for transposase-accessible chromatin using sequencing (ATAC-seq) is also an effective technology for identifying regulatory element regions.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> The combination of ChIP-seq and ATAC-seq data may be used to more accurately identify hypersensitive TF-binding elements within large enhancer regions. A python package, <italic>Coltron</italic> (<ext-link ext-link-type="uri" xlink:href="https://pypi.python.org/pypi/coltron" id="intref0015">https://pypi.python.org/pypi/coltron</ext-link>), has been developed to identify CRCs by integrating H3K27ac ChIP-seq and ATAC-seq data. Ott et al. used <italic>Coltron</italic> to identify the CRCs of chronic lymphocytic leukemia (CLL) cells and completely characterized the active <italic>cis</italic>-regulatory landscape of the CLL epigenome.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> They found that <italic>PAX5</italic> was regulated by SEs and played a dominant role in CLL and was essential for cell survival. BET bromodomain inhibitors prevented the expression of intracellular SE-dependent genes, selectively inhibited the CRCs of CLL, and had effective antitumor activity. Thus, different algorithms demonstrated their advantages and the integration of the two approaches provided the greater success in CRC reconstruction.</p>
    <p id="p0025">Motivated by the identification of CRCs in various cell/tissue types and the systematic study of SE-driven CRC mechanisms, this study identified CRCs and core TFs using <italic>CRC mapper</italic> and <italic>Coltron</italic>, and generated the landscape of CRCs driven by SEs. Notably, the study identified a large number of CRCs in human cells/tissues and extensive human CRC models. We also conducted a comprehensive biological analysis of these CRCs and core TFs. First, we calculated and compared the CRCs and core TFs using the two methods, and divided core TFs into common TFs, moderate TFs, and specific TFs to validate the different biological features among them, including sequence conservation, CRC activity, and genome binding affinity. Second, a fully connected module was located from a common CRC network. Functional enrichment analyses highlighted the essential functions maintained by the modules of the common CRC networks. Survival analysis suggested that the module provided clinical guidance for cancer prognosis. Third, tissue-specific TF-TF interactions were used to construct tissue-specific CRC networks, which were highly related to cell identity. The core TFs in tissue-specific CRC networks could include disease markers, and have regulatory potential for cancer immunotherapy. Finally, to extend the impact and use of CRCs across human cells/tissues, we developed a user-friendly resource platform named CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0020">http://www.licpathway.net/crcdb/index.html</ext-link>). CRCdb can integrate global information of core TFs, SEs, and TF genes, and the regulatory element interactions within CRC networks.</p>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>Identification and description of CRCs in multiple cell/tissue types</title>
      <p id="p0030">In this study, we obtained H3K27ac ChIP-seq data from NCBI GEO/SRA,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> ENCODE,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Roadmap,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> and GGR.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> We identified SEs and their elements in a large number of cell/tissue samples. Based on the closest active genes of the SEs, two identification methods, <italic>CRC mapper</italic> and <italic>Coltron</italic>, were used to systematically identify CRCs driven by SEs. Then, the resource platform CRCdb was developed to present the extensive annotation information on CRCs and core TFs (<xref rid="fig1" ref-type="fig">Figure 1</xref>A). In total, 367,495 and 8,235,853 CRCs were identified from ∼500 samples by the two methods, respectively. Approximately 500 core TFs formed these CRCs in more than 50 tissues, binding to more than 30,000 SEs (<xref rid="fig1" ref-type="fig">Figure 1</xref>B; <xref rid="mmc2" ref-type="supplementary-material">Table S1</xref>). We then compared the TF overlap ratios of the two methods across 22 major tissues. The results showed that <italic>Coltron</italic> identified more core TFs than <italic>CRC mapper</italic>, and nearly 50%–70% of the core TFs were identified by both methods, indicating that H3k27ac peaks or valleys recruited different core TFs (<xref rid="fig1" ref-type="fig">Figure 1</xref>C; <xref rid="mmc3" ref-type="supplementary-material">Table S2</xref>). Heart tissue had the highest number of core TFs. Seventy-two overlapped TFs identified by the two methods were obtained from the heart tissue samples (the TF list is provided in <xref rid="mmc3" ref-type="supplementary-material">Table S2</xref>). We performed functional enrichment for these TFs, and the results showed that all TFs were enriched in cardiovascular-related diseases, including the known cardiovascular disease genes <italic>TBX5</italic>, <italic>TBX20</italic>, <italic>STAT3</italic>, <italic>MEF2A</italic>, <italic>MEIS1</italic>, <italic>HIF1A</italic>, and <italic>GATA4</italic> (<xref rid="fig1" ref-type="fig">Figure 1</xref>D). Those results inspired us to investigate the role of common TFs and specific TFs in different biological characteristics.<fig id="fig1"><label>Figure 1</label><caption><p>Identification and description of CRCs in multiple cell/tissue types</p><p>(A) Data sources and research contents. (B) Statistical data. (C) TF overlap ratios of 2 methods across 22 major tissues. In the histogram, pink represents <italic>Coltron</italic> and green represents <italic>CRC mapper</italic>. The x axis represents the tissue name and the y axis represents the number of TFs. In the pie chart, red represents the overlap ratio of TFs in the two methods and blue represents the specific ratio. (D) The overlapping TFs from the two methods identified in heart tissue enriched in cardiovascular-related diseases. The x axis is the enriched disease name and the y axis is the number of TFs. The color of the dot represents the significance level. The redder the color, the higher the significance level of the enrichment. The size of dot represents the number of enriched TFs. The larger the dots, the more TFs were enriched. (E) The distribution of core TFs present in different numbers of cell/tissue types using the two methods. The color represents the number of tissue types. (F) Heatmap of the specific and common TFs based on the TF occurrences (1 or 0) in different tissue/cell samples. <italic>AR</italic> and <italic>NKX3-</italic><italic>1</italic> appeared in the prostate, <italic>PAX3</italic> appeared in skeletal muscle.</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0035">To reveal the distribution of CRCs, the frequency of core TFs present in different cell/tissue types was counted. The <italic>CRC mapper</italic> results showed that 12.2% of core TFs were only present in one cell/tissue type, while the <italic>Coltron</italic> results showed that 9.8% of core TFs were only present in one cell/tissue type. In addition, the maximum number of core TFs appeared in between 2 and 30 cell/tissue types. A small number of core TFs appeared in more than 30 cell/tissue types using both methods (<xref rid="fig1" ref-type="fig">Figure 1</xref>E). Furthermore, we calculated the specific TFs and common TFs based on the TF occurrences in different samples. The results showed that some known markers were identified in specific cell/tissue type, such as <italic>AR</italic> and <italic>NKX3-</italic><italic>1</italic> in prostate cells and <italic>PAX3</italic> in skeletal muscle (<xref rid="fig1" ref-type="fig">Figure 1</xref>F). The results demonstrated that CRCs and core TFs had different distributions and characteristics in different cell/tissue types. Some CRCs and core TFs occurred specifically in a few tissues, while others were common in most tissues, thus, requiring further classification research.</p>
    </sec>
    <sec id="sec2.2">
      <title>The specific and common TFs of CRCs exhibit different biological characteristics</title>
      <p id="p0040">We identified CRCs and their core TFs in numerous human cell/tissue types. By counting the number of core TFs that appeared in different numbers of cell/tissue types, <italic>Coltron</italic> identified 53 core TFs present in only 1 tissue, while 36 core TFs were present in more than 35 tissues. <italic>CRC mapper</italic> exhibited similar results, with 62 core TFs identified in only one cell/tissue, and 34 core TFs present in more than 35 cells/tissues (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). Based on those results, we defined the core TFs in only one cell/tissue as “specific” and those in more than 35 cells/tissues as “common.” The other core TFs that appeared in between 2 and 35 cell/tissue types were defined as “moderate.” The common TFs were similar in both methods, while the specific TFs were largely different (<xref rid="fig2" ref-type="fig">Figure 2</xref>A). Thus, the common TFs were prevalent in some common tissues and tended to perform essential functions. However, the specific TFs tended to perform specific functions and varied greatly in different tissues. For example, we identified that the AP-1 family, including <italic>FOS</italic>, <italic>JUN</italic>, <italic>JUNB</italic>, and <italic>JUND</italic> were common TFs, and composed the CRCs in more than 35 tissues. Previous study validated that the AP-1 family of TFs plays fundamental roles in cell differentiation, proliferation, and apoptosis.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> Some TFs, such as <italic>RARA</italic>, <italic>SMAD3</italic>, <italic>KLF7</italic>, <italic>BCL6</italic>, <italic>FOXO3</italic>, <italic>RUNX1</italic>, and <italic>NR2F2</italic>, were also classified as common TFs, which have been implicated in the regulation of gene activity, cell proliferation, cell death, and tumor survival.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="bib19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="bib20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> However, <italic>AR</italic> in prostate cells,<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref>
<italic>POU1F1</italic> in brain tissue,<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref>
<italic>SHOX</italic> in bone,<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref>
<italic>ZSCAN4</italic> in placenta tissue,<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> and <italic>VSX2</italic> in retina<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> were considered specific TFs in this study. Those TFs have been shown to function in specific tissues by TF marker, which is a comprehensive manually curated database of TFs and related markers with experimental evidence from human-specific cell/tissue types.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref><fig id="fig2"><label>Figure 2</label><caption><p>Biological characteristics of specific and common TFs</p><p>(A) Core TFs in only one cell/tissue are “specific” TFs, core TFs in more than 35 cells/tissues are “common” TFs, and core TFs in 2–35 cell/tissue types are “moderate” TFs. The x axis is the number of tissues and the y axis is the number of TFs. The pie charts in the middle represent the overlap of common and specific TFs between the two methods, respectively. (B) The number of SEs that specific, common, and moderate TFs bind to. The x axis is the number of tissues and the y axis is the number of SEs. (C) Conservation score (two-tailed log rank test, p&lt;0.05) of specific, moderate, and common TFs, respectively. (D) CRC activity score (two-tailed log rank test, p&lt;0.05) of specific, moderate, and common TFs, respectively. (E) The genome binding features of the common TF, <italic>JUND</italic>, and the specific TF, <italic>AR</italic>, based on TF ChIP-seq data. (F) The binding affinity to the SEs of <italic>JUND</italic> and <italic>AR</italic>.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0045">SE is composed of many active enhancer elements, which can be bound by protein complexes composed of various TFs and transcription cofactors, thereby regulating the expression level of related genes and ultimately affecting cell fate.<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> In a CRC, multiple core TFs bind to their own SEs and the SEs of each other to regulate the expression of TF genes. In this study, we observed the number of SEs that specific, moderate, and common TFs bound to. The results showed that common TFs bound to the largest number of SEs, while the specific TFs bound to the smallest number of SEs (<xref rid="fig2" ref-type="fig">Figure 2</xref>B). Those data suggested that common TFs tended to perform similar regulatory functions in different cells by binding to more common SEs, while specific TFs play specific roles in maintaining cell identity, which can be achieved by binding to the relatively few tissue-specific SEs.</p>
      <p id="p0050">We calculated the conservation score and CRC activity score of specific, moderate, or common TFs. As expected, the most conserved group of core TFs was that of the common TFs (two-tailed log rank test, p &lt; 0.05, <xref rid="fig2" ref-type="fig">Figure 2</xref>C). This was expected as common TFs are the most highly conserved TF class across all common cell/tissue types. We also found that specific TFs had the highest CRC activity scores (two-tailed log rank test, p &lt; 0.05, <xref rid="fig2" ref-type="fig">Figure 2</xref>D), implying the significant role of specific TFs on tissue-specific regulation. Moreover, we compared the genome binding features of diverse TF types based on TF ChIP-seq data. The results showed that the common TF <italic>JUND</italic> had more similar binding features in different tissues than the specific TF <italic>AR</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>E). Notably, we found that <italic>AR</italic> bound more distal regions in prostate cell lines than other non-specific tissues, implying that TFs preferred to exert important functions by binding to the distal regions. This result suggested that TFs maintain cell identity and control tissue-specific regulation based on their binding to distal enhancers and SEs. The results also showed that the <italic>JUND</italic> peaks revealed the binding affinity to the SEs of <italic>JUND</italic> across multiple tissues; however, only prostate-related <italic>AR</italic> peaks revealed the binding affinity to the SEs of <italic>AR</italic> (<xref rid="fig2" ref-type="fig">Figure 2</xref>F).</p>
    </sec>
    <sec id="sec2.3">
      <title>Local modules in common CRC networks play important biological functions</title>
      <p id="p0055">The transcriptional state of a cell emerges from an underlying gene regulatory network in which a limited number of TFs and cofactors regulate each other and their downstream target genes. Thus, we counted the number of TF-TF interactions of CRCs that appeared in different numbers of cell/tissue types, and showed their distribution (<xref rid="fig3" ref-type="fig">Figure 3</xref>A). Then, all the TF-TF interactions of CRCs that appeared in more than 15 cell/tissue types were integrated into a common CRC network. Analysis of the common CRC network can provide a global view of the regulatory relationships involved in the interactions among core TFs. However, the common CRC network was a huge network with a large number of core TF nodes and their interactions. It is difficult to find more detailed information from such a huge network and, therefore, we located local modules to reveal the detailed modular organization. Based on the common CRC network, a fully connected module consisting of 18 core TF nodes was identified (<xref rid="fig3" ref-type="fig">Figure 3</xref>B). According to gene expression data from GTEx,<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> Pearson correlation coefficients (PCCs) were calculated between any two core TFs in the module. The 18 core TFs showed positive correlation with each other to varying degrees (<xref rid="fig3" ref-type="fig">Figure 3</xref>C, upper triangle). Meanwhile, we counted the overlap of the 18 core TFs in the one-step neighbors of the common CRC network. The results showed that the TFs shared many of the same one-step neighbors in the network (<xref rid="fig3" ref-type="fig">Figure 3</xref>C, lower triangle). Those results demonstrated that the core TFs of the module were structurally closely connected, expressed positive correlation, and tended to cluster together to perform important biological functions.<fig id="fig3"><label>Figure 3</label><caption><p>The features of local modules in common CRC networks</p><p>(A) The distribution of TF-TF interactions of CRCs in different numbers of cell/tissue types. Different colors represent different numbers of tissue types. The larger the area of the rings, the more TF-TF interactions. (B) A fully connected module consisted of 18 core TF nodes. (C) The upper triangle represents PCCs between any two core TFs in the module. The depth of the color represents the level of the PCC score. The darker the color, the greater the score. The lower triangle represents the shared one-step neighbors between any two core TFs in the common CRC network. The color and size of the node represents the number of shared one-step neighbors. The large and blue nodes represent the more shared one-step neighbors; the small and red nodes represent the fewer shared one-step neighbors. The x axis and y axis represent the 18 core TFs of module. (D) GO and KEGG enrichment analyses with hypergeometric test p &lt; 0.01 for the 18 core TFs. (E) Different mutation frequencies among the 18 core TFs. (F) The HR of the module in different tumor patients. The x axis represents the disease name and the y axis represents the TF name. The color represents the log10(HR). (G) Overall survival curves of the module in KIRC, LGG, and pan-cancer patients with two-tailed log rank test p &lt; 0.001.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0060">GO and KEGG enrichment analyses found that the core TFs of the module were significantly involved in the functions of cell differentiation, nucleus, positive regulation of transcription, TF activity, transcription regulatory region sequence-specific DNA binding, and transcriptional misregulation in cancer (hypergeometric test, p &lt; 0.01, <xref rid="fig3" ref-type="fig">Figure 3</xref>D). Those results agreed with our expectations. TFs control numerous cellular processes, including proliferation, differentiation, apoptosis, and inflammation. Abnormal TF activity has been implicated in a variety of diseases, especially cancer. The correct subcellular localization of TFs determines their activation status, implicating the nuclear transport receptors as key players in regulating TF function. Dysregulation of the nuclear transport machinery has been described in multiple cancer types.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> We next explored the mutations among the core TFs in the module and found different mutation frequencies (<xref rid="fig3" ref-type="fig">Figure 3</xref>E). The core TFs in the module all participated in similar biological processes and jointly participated in transcriptional regulation-related molecular functions.</p>
      <p id="p0065">To further assess the prognostic performance of the module, survival analysis was performed on the 18 core TFs. From the results of the Cox proportional hazards model, we found that the module had different hazard ratio (HR) values in different tumor patients (<xref rid="fig3" ref-type="fig">Figure 3</xref>F). In particular, most of the core TFs in the module had HR values less than 1 in kidney renal clear cell carcinoma (KIRC) patients, which indicated that the core TFs of the module were protective factors in KIRC and played a protective role in the survival of KIRC patients. On the contrary, most of the core TFs in the module had HR values greater than 1 in brain lower-grade glioma (LGG) patients, which means that the core TFs were injurious factors in LGG and harmful to LGG patient survival. Kaplan-Meier survival curves were plotted for the KIRC, LGG, and pan-cancer patient groups. Consistent with the above HR results, KIRC patients in the low-risk score group had a significantly shorter overall survival than those in the high-risk score group (two-tailed log rank test, p = 1.0e−05, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). However, for LGG patients, the overall survival time of the high-risk group was significantly shorter than that of low-risk group (two-tailed log rank test, p = 2.7e−05, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). The module also exhibited good prognostic performance in pan-cancer patients (two-tailed log rank test, p = 4.5e−08, <xref rid="fig3" ref-type="fig">Figure 3</xref>G). Those findings indicated that the local module in the common CRC network provided clinical guidance for cancer prognosis.</p>
    </sec>
    <sec id="sec2.4">
      <title>Specific network analysis reveals tissue-specific CRC networks</title>
      <p id="p0070">After deep excavation, we not only found that some common TF-TF interactions in the CRCs appeared in more than 15 cell/tissue types but, also, a number of specific TF-TF interactions only appeared in one kind of cell/tissue type. In addition, the results in <xref rid="fig1" ref-type="fig">Figure 1</xref>C suggest that nearly half of the core TFs were non-redundant between the <italic>Coltron</italic> and <italic>CRC mapper</italic> methods. Thus, we calculated the frequencies of TF-TF interactions in CRCs in several major human cell/tissue types using both methods (<xref rid="fig4" ref-type="fig">Figure 4</xref>A). It should be noted that there was a small subset of specific TF-TF interactions that only appeared in one major cell/tissue type. Those interactions were considered as tissue-specific TF-TF interactions. Hypergeometric tests identified substantial overlap between the core TFs of the tissue-specific TF-TF interactions and TFs in a TF-marker database<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> with p values less than 0.01 (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). In heart tissue and prostate tissue, in particular, there was significantly more overlapped TFs (hypergeometric test, p &lt; 0.01, <xref rid="fig4" ref-type="fig">Figure 4</xref>B). The results indicated that the core TFs of the tissue-specific TF-TF interactions in CRCs could be used as marker genes, which were the signatures in specific cells and tissues.<fig id="fig4"><label>Figure 4</label><caption><p>Analysis of tissue-specific CRC networks</p><p>(A) The frequency of TF-TF interactions of the CRCs in several major cell/tissue types. The x axis represents the tissue name. Different colors represent different numbers of tissue types. (B) The overlap between core TFs of the tissue-specific CRC network and marker TFs in the TF-marker database (hypergeometric test, p &lt; 0.01). The color of the dots represents the significance level. The redder the dot, the higher the significance level. (C) A heart-specific CRC network. The size of the dot represents the degree. The larger the dot, the greater the degree. The gene names in red represent the hub nodes. (D) A prostate-specific CRC network. The size of the dot represents the degree. The larger the dot, the greater the degree. The gene names in red represent the hub nodes. (E) The overlap between the target genes of core TFs in the tissue-specific CRC network across multiple tissues. The overlap between heart and muscle tissues was statistically significant (p &lt; 10e−22). The overlap between bone marrow and blood tissues was statistically significant (p &lt; 10e−22).</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0075">Heart-tissue-specific TF-TF interactions and prostate-tissue-specific TF-TF interactions were obtained to construct a heart-specific CRC network and a prostate-specific CRC network, respectively (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). From the two networks, we can see that some core TFs had relatively greater node degrees. Studies found that the node degree of genes in biological networks represents their regulatory potential; therefore, we defined the top 10 core TFs with the greatest node degrees as the hub nodes. For example, in the heart-specific CRC network, <italic>ZNF524</italic>, <italic>NKX2-</italic><italic>5</italic>, <italic>TBX20</italic>, <italic>CEBPD</italic>, <italic>ERF</italic>, <italic>ATF5</italic>, <italic>HLF</italic>, <italic>SP2</italic>, <italic>HBP1</italic>, and <italic>GATA4</italic>, were defined as the hub nodes (<xref rid="fig4" ref-type="fig">Figure 4</xref>C). It is worth noting that the hubs regulated more other nodes in the network and contained some known heart-related TFs. <italic>NKX2-</italic><italic>5</italic> is a key TF in early cardiac development, which regulates not only the initiation but also the usage of poly(A) sites during heart development.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref>
<italic>TBX20</italic> is a T-box TF that plays essential roles in the development and maintenance of the heart. <italic>T</italic><italic>BX</italic><italic>20</italic> has been reported to be critical for mammalian cardiac development and function.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> In a similar way, <italic>HOXB13</italic>, <italic>NKX3-</italic><italic>1</italic>, <italic>NFAT5</italic>, <italic>ELK4</italic>, <italic>IRX5</italic>, <italic>SP8</italic>, <italic>AR</italic>, <italic>SPDEF</italic>, <italic>DLX2</italic>, and <italic>ISL1</italic> were identified as hub nodes in the prostate-specific CRC network (<xref rid="fig4" ref-type="fig">Figure 4</xref>D). Those hubs were associated with more regulatory relationships than the other nodes in the network, showing stronger regulatory potential. The androgen receptor (<italic>AR</italic>) is a major regulator of lipid metabolism, controlling the expression of more than 20 enzymes involved in the synthesis, uptake, and metabolism of lipids.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> The <italic>AR</italic> has been widely recognized as a key driver of prostate cancer. In addition, <italic>HOXB13</italic> is a member of the homeobox family TFs, which is expressed mainly in the adult prostate and at a much lower level in the colorectum.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> Transgenic mice studies have shown that <italic>HOXB13</italic> expression is required for epithelial differentiation of the ventral prostate.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Taken together, these results demonstrated that tissue-specific CRC networks can capture specific core TFs, some of which are markers for diseases and exist as hubs in the network.</p>
      <p id="p0080">We also detected the overlap between the target genes of core TFs in the tissue-specific CRC network in major human cell/tissue types. Core TFs regulate the expression of their target genes by directly binding to their SEs. Different tissues have exhibited substantial overlap between target genes (<xref rid="fig4" ref-type="fig">Figure 4</xref>E). For example, the overlap between heart and muscle tissues was identified with a hypergeometric p value &lt;10e−22. The heart is a muscle composed of specially differentiated muscle cells, many of which are clustered and surrounded by connective tissue into muscle bundles.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> Similarly, the overlap between bone marrow and blood tissues was also identified with a hypergeometric p value &lt;10e−22. Those results suggest that core TFs acting as hubs in the tissue-specific CRC networks regulate the expression of relatively more target genes, and that similarities may exist between the target genes in different diseases.</p>
    </sec>
    <sec id="sec2.5">
      <title>Significance of prostate-specific CRC network</title>
      <p id="p0085">Next, we used the prostate-specific CRC network to investigate the potential role and significance of tissue-specific CRC networks in cancer biology. The top 10 core TFs with the greatest node degree were selected for further analysis, including <italic>HOXB13</italic>, <italic>NKX3-</italic><italic>1</italic>, <italic>NFAT5</italic>, <italic>ELK4</italic>, <italic>IRX5</italic>, <italic>SP8</italic>, <italic>AR</italic>, <italic>SPDEF</italic>, <italic>DLX2</italic>, and <italic>ISL1</italic>. First, we compared the average expression of these TFs across cancers. They were exceptionally highly expressed in prostate cancer (<xref rid="fig5" ref-type="fig">Figure 5</xref>A), suggesting that these TFs functioned in a tissue-specific pattern and were crucial for the pathological processes of prostate cancer. Then, we used the GREAT tool<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> to perform function analyses for the binding SEs of the core TFs in prostate-related samples, and found that the binding SEs were highly related to the proliferation of prostate epithelium and prostate development (<xref rid="fig5" ref-type="fig">Figure 5</xref>B). We further calculated the TCGA ATAC-seq signal in these SE regions. The results showed that the activity of ATAC-seq peaks within these SEs were higher than other background peaks (rank sum test, p &lt;0.001, <xref rid="fig5" ref-type="fig">Figure 5</xref>C). Moreover, GWAS SNP mapping results showed that these SEs could enrich the prostate-related SNPs (<xref rid="fig5" ref-type="fig">Figure 5</xref>D). The above results indicated that the core TFs of the tissue-specific CRC networks had broad regulatory effects in tissue-specific biology.<fig id="fig5"><label>Figure 5</label><caption><p>Significance of the prostate-specific CRC network</p><p>(A) The expression distribution of the top 10 core TFs with the greatest degree of the prostate-specific CRC network in different cancers. The x axis represents the cancer name and the y axis indicates the RPKM value. (B) Function annotation for the binding SEs of the top 10 core TFs. (C) TCGA ATAC-seq signal in SE regions and other background peaks (rank sum test, p &lt; 0.001). (D) GWAS SNP mapping results of the SEs. (E) TIMER2 results of multiple immune cells. (F) The correlations between core TFs and the cell infiltration levels of immune cells. <italic>AR</italic>, <italic>NFAT5</italic>, and <italic>SPEDF</italic> are positively or negatively correlated with immune cell infiltration.</p></caption><graphic xlink:href="gr5"/></fig></p>
      <p id="p0090">Previous studies suggested that immunotherapy is effective in cancer.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref><sup>,</sup><xref rid="bib41" ref-type="bibr"><sup>41</sup></xref><sup>,</sup><xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> Immunotherapy is re-emerging as a viable option for prostate cancer, especially castration-resistant prostate cancer, to stimulate antitumor immunity.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> The TIMER2 results showed that multiple immune cells exhibited high infiltration in prostate cancers, including dendritic cells, CD8<sup>+</sup> T cells, and neutrophils (<xref rid="fig5" ref-type="fig">Figure 5</xref>E). We then evaluated the correlations between core TFs and the cell infiltration levels of immune cells using expression data and TIMER2 data. The results showed that some core TFs were positively or negatively correlated with immune cell infiltration, such as <italic>AR</italic>, <italic>NFAT5</italic>, and <italic>SPEDF</italic>, thus suggesting that these TFs had potential regulatory effects on tumor microenvironments (<xref rid="fig5" ref-type="fig">Figure 5</xref>F). We identified that the expression of the prostate-specific core TF, <italic>AR</italic>, was highly related to CD8<sup>+</sup> T cell infiltration (PCC = 0.85), indicating the crosstalk between <italic>AR</italic> and CD8<sup>+</sup> T cell activity. Interestingly, Guan et al. found that blocking <italic>AR</italic> sensitized tumor-bearing hosts to effective checkpoint blockade by directly enhancing CD8<sup>+</sup> T cell function.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref>
<italic>AR</italic> inhibited the activity and stemness of male tumor-infiltrating CD8+ T cells by regulating epigenetic and transcriptional differentiation programs.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> These results suggested that prostate cancer cells might resist CD8<sup>+</sup> cell infiltration by upregulating the expression of <italic>AR</italic>. <italic>SPDEF</italic> was revealed as a tumor suppressor in prostate cancer by disrupting a positive feedback loop in the regulation of F<italic>OXM</italic>1.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> In airway epithelial cells, overexpression of <italic>SPDEF</italic> inhibited LPS-induced neutrophilic infiltration and bacterial clearance.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> We inferred that <italic>SPDEF</italic> could regulate neutrophil infiltration to overcome prostate cancer. <italic>NFAT5</italic> was not investigated in prostate cancer or immune cell infiltration, but the results showed that <italic>NFAT5</italic> was highly related to multiple immune cell infiltrations, which could be considered as possible immunotherapy targets in prostate cancer patients. Furthermore, we also investigated the regulatory potentials of tissue-specific CRC network-driven core TFs on immune infiltration in other tumors, such as colon adenocarcinoma, glioblastoma multiforme, lung adenocarcinoma, pancreatic adenocarcinoma, and uterine carcinosarcoma (UCS) (<xref rid="mmc1" ref-type="supplementary-material">Figure S1</xref>). Numerous core TFs of the tissue-specific CRC network, such as <italic>ASCL2</italic>, <italic>SOX6</italic>, <italic>TBX5</italic>, <italic>FOXP2</italic>, and <italic>SOX17</italic>, were identified as candidate regulators in tumor immunotherapy, which can interfere with tumor cell growth by regulating the activity of immune cells.</p>
    </sec>
    <sec id="sec2.6">
      <title>CRCdb, a platform for the landscape of CRCs and core TFs</title>
      <p id="p0095">To bridge the gap between big data information and biologists, we developed a user-friendly resource platform, CRCdb (<ext-link ext-link-type="uri" xlink:href="http://www.licpathway.net/crcdb/index.html" id="intref0025">http://www.licpathway.net/crcdb/index.html</ext-link>), to identify the CRCs of human cell/tissue types. The current version of CRCdb documents over 500 samples from NCBI, ENCODE, and Roadmap. For all samples, CRCs were identified using a unified system environment, taking advantage of <italic>Coltron</italic> and <italic>CRC mapper</italic>. The number of human samples has been increased nearly 3-fold compared with the existing database and the scale of data is five times larger than the existing database. The number of CRCs in CRCdb is 8,611,549. CRCdb also provides detailed information of CRCs (the most representative CRC and all other CRCs), supporting the display of frequency of TFs in CRCs and the indegree/outdegree of TFs. Users can easily browse CRCdb content through a user-friendly interface.</p>
      <p id="p0100">Using CRCdb, there are three ways to scan the CRCs and core TFs. First, users can choose “sample-based browse” or “TF-based browse” and scan the detailed CRC information in different cell/tissue types on the browse page (<xref rid="fig6" ref-type="fig">Figures 6</xref>A–6G). Second, users can search and view information of interest in a targeted way through clicking “search CRC by sample-based,” “search CRC by TF-based,” or “search CRC by tissue-based” (<xref rid="fig6" ref-type="fig">Figures 6</xref>H–6K). Furthermore, three kinds of analytical strategies allow users to perform detailed analyses of CRCs, core TFs, SEs, and SE-associated TF genes (<xref rid="fig6" ref-type="fig">Figure 6</xref>L). In addition, download links are provided for users to batch download information.<fig id="fig6"><label>Figure 6</label><caption><p>Overview of CRCdb</p><p>(A–G) Detailed CRC information in different cell/tissue types on the “Browse” page. (H–K) Detailed CRC information through “Search” function. (L) Three types of analytical strategies.</p></caption><graphic xlink:href="gr6"/></fig></p>
    </sec>
    <sec id="sec2.7">
      <title>Case study of downstream gene-based CRC analysis in CRCdb</title>
      <p id="p0105">We performed “Analyze CRCs by Downstream gene” by inputting cardiac marker genes (<italic>NKX2-</italic><italic>5</italic>, <italic>MEF2C</italic>, and <italic>MEF2D</italic>) as the gene input list to evaluate CRCdb for fields related to cardiovascular functions and diseases (<xref rid="fig7" ref-type="fig">Figure 7</xref>A). The analytical results returned core TFs in CRCs associated with the input genes, including <italic>ATF3</italic>, <italic>GATA4</italic>, <italic>JUN</italic>, <italic>MEF2C</italic>, <italic>NR4A1</italic>, and <italic>TBX5</italic> (<xref rid="fig7" ref-type="fig">Figure 7</xref>B). The SE distribution table for these core TFs showed that most SEs were distributed in heart tissue-related samples (<xref rid="fig7" ref-type="fig">Figure 7</xref>C). For example, SEs associated with <italic>JUN</italic>, <italic>GATA4</italic>, and <italic>TBX5</italic> were mainly distributed in right cardiac atrium tissues. SEs associated with <italic>JUN</italic>, <italic>NR4A1</italic>, <italic>GATA4</italic>, and <italic>MEF2C</italic> were mainly distributed in coronary artery tissues. These findings were consistent with previous findings that the upstream enhancer of <italic>NKX2-</italic><italic>5</italic> had high binding affinity to <italic>GATA4</italic>,<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> thus, suggesting that core TFs in SE-driven CRCs can enhance the transcription of <italic>NKX2-</italic><italic>5</italic> in cardiac development. Other SE-regulated core TF-gene pairs have also identified potential interactions during heart development, the dysregulation of which can result in the occurrence of cardiovascular diseases.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> The ranked plot for SEs with the highest median H3K27ac scores were developed for each TF (<xref rid="fig7" ref-type="fig">Figure 7</xref>D). By clicking the sample ID, users can further obtain detailed information about CRCs and core TFs in specific tissue. For example, when clicking “Sample_02_381,” users can view a brief overview of the most representative CRC model (<xref rid="fig7" ref-type="fig">Figure 7</xref>E). More information about the frequency of core TFs in CRCs and the indegree/outdegree of core TFs are provided to the users (<xref rid="fig7" ref-type="fig">Figure 7</xref>E). Generally, the higher the frequency of a TF, the more important the TF is under this sample. A TF with high indegree and outdegree values is also considered to be an important TF. Thus, <italic>GATA4</italic> and <italic>NR4A1</italic> become the most important core TFs under this sample. Collectively, we performed a specific case study of CRC analysis for cardiac tissue in CRCdb. The annotated core TFs have been shown to be directly related to cardiovascular-related diseases. The results revealed the significance of our platform for research of CRCs and core TFs in human tissues.<fig id="fig7"><label>Figure 7</label><caption><p>Results of a case study in CRCdb</p><p>(A) Three cardiac marker genes (<italic>NKX2-</italic><italic>5</italic>, <italic>MEF2C</italic>, and <italic>MEF2D</italic>) as the gene input list to perform “Analyze CRCs by Downstream gene” function in the “Analysis” page. (B) All of the core TFs in CRCs associated with the input genes, including <italic>ATF3</italic>, <italic>GATA4</italic>, <italic>JUN</italic>, <italic>MEF2C</italic>, <italic>NR4A1</italic>, and <italic>TBX5</italic>. (C) SE distribution table related to the core TFs in CRCs. (D) Ranked plot for the SEs with the highest median H3K27ac scores. (E) Detailed information of “Sample_02_381”.</p></caption><graphic xlink:href="gr7"/></fig></p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion</title>
    <p id="p0110">TFs play a key regulatory role in cellular activities and affect the normal growth and differentiation of human cells and tissues. Many tremendous advances have been made for the control of transcription,<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> but the core TFs of CRCs that control gene expression programs have yet to be mapped in most human tissues/cells. The CRCs driven by SEs can be used to analyze the coordinated regulation of intracellular TFs.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> The core TFs that constitute the CRCs are conducive to the discovery of key regulatory genes.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> Thus, this study described a model of CRCs driven by SEs for ∼500 human cell and tissue samples, thus providing a foundation for comprehensive studies of core transcription regulatory programs in diverse human cell/tissue types. The integration of the <italic>Coltron</italic> and <italic>CRC mapper</italic> methods was validated to capture more comprehensive information than each method individually. The CRCs and core TFs exhibited different distributions in different cell/tissue types. Some were only present in a few cells/tissues, while others were common in most cells/tissues. Thus, the core TFs were classified into “specific,” “common,” and “moderate.” We found that specific and common TFs exhibited different characteristics, including different genome binding affinities, sequence conservation, and CRC activity. <italic>JUND</italic> was a common TF and <italic>AR</italic> was a specific TF. It is also worth noting that <italic>JUND</italic> displayed similar binding features in different tissues, but <italic>AR</italic> bound more distal regions only in prostate cell lines. In addition, <italic>JUND</italic> binding peaks revealed binding affinity to the SEs of <italic>JUND</italic> across multiple tissues, but only prostate-related <italic>AR</italic> peaks bound to the SEs of <italic>AR</italic>.</p>
    <p id="p0115">Transcription regulatory networks (TRNs) provide important information in revealing the essence of gene transcription. Numerous gene expression-based methods have been proposed to construct TRNs, such as <italic>GENIE3</italic><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> and <italic>ARACNe</italic>,<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> using random forest and mutual information, respectively. Compared with epigenetics data-based methods, <italic>Coltron</italic> and <italic>CRC mapper</italic>, gene expression-based methods have advantages in identifying more TF-TF interactions, but also produce more false positive results. Mechanically, TFs participate in transcription regulation to control cell identity by binding to DNA regulatory regions, including enhancers and SEs. The TF-TF interactions identified in our epigenetics data-based methods were based on the TF binding affinity of SEs. The results of our study validated the regulatory effects of these TF-TF interactions in specific tissues. In addition, we used the top 10 core TFs with the greatest node degree in the prostate-specific CRC network (<xref rid="fig5" ref-type="fig">Figure 5</xref>A) as a case to illustrate the differences between the epigenetics data-based methods and gene expression-based methods. Furthermore, we constructed TRNs by inputting the human TF list and gene expression matrix for prostate adenocarcinoma in TCGA, using the <italic>GENIE3</italic> and <italic>ARACNe</italic> methods, respectively. The TF-TF subnetworks were extracted from the TRNs by inputting core TFs from our prostate-specific CRC network. The top 10 TFs were subsequently obtained by calculating the node degree of the subnetworks. Only two intersections of the top 10 TFs (<italic>HOXB13</italic> and <italic>NKX3-</italic><italic>1</italic>) could be identified by all the methods (<xref rid="mmc1" ref-type="supplementary-material">Figure S2</xref>), implying that gene expression-based methods are insufficient to reproduce the results that were returned from the epigenetics data-based methods.</p>
    <p id="p0120">The return of a gene node to the network reveals its global properties and topological features. Therefore, we extracted the common TF-TF interactions of CRCs that appeared in more than 15 cell/tissue types to construct a common CRC network. The TFs of the fully connected module in the common CRC network expressed positive correlation, shared many same one-step neighbors, and performed good prognostic performance. We also focused on a number of specific TF-TF interactions that only appeared in one kind of cell/tissue type, which were used for constructing the tissue-specific CRC network. Core TFs in the tissue-specific CRC network could capture disease markers and were shown to be highly related to cell identity. Cancer immunotherapy experiments further suggested that the core TFs in the tissue-specific CRC network had potential regulatory effects on the tumor microenvironment.</p>
    <p id="p0125">To detail the landscape of human SE-driven CRCs, a user-friendly platform, CRCdb, was developed. It contains the detailed information of CRCs and core TFs analyzed in this study, as well as some other information of CRCs that were not discussed in this study, such as the most representative CRC, frequency of TFs in CRCs, and indegree/outdegree of TFs. Users can easily browse the CRCdb content through a user-friendly interface.</p>
    <p id="p0130">In summary, our work provides fundamental and extensive insights into the transcriptomic and epigenomic landscape of human CRCs and highlights the functional and regulatory roles of core TFs in maintaining cell identity and disease regulation. Remarkably, the study provided a large quantity of CRCs and extremely comprehensive human CRC models in massive human cell/tissue samples. With the continual accumulation of data, we will extend the scale of the CRCs and investigate the regulatory roles in the single-cell perspective, as well as update our CRCdb platform. We believe that CRCdb is a useful and effective platform for exploring and elucidating TF functions in complex diseases. Continued investigation of the human CRCs identified here will greatly improve our understanding of the mechanisms of TF-related therapies.</p>
  </sec>
  <sec id="sec4">
    <title>Materials and methods</title>
    <sec id="sec4.1">
      <title>Data sourcing and filtering</title>
      <p id="p0135">This study integrated a large volume of H3K27ac ChIP-seq data from NCBI GEO/SRA,<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> ENCODE,<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Roadmap,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> and GGR.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> In these public databases, we entered the keyword “H3K27ac” to search for samples, and obtained information for more than 2,000 original samples, including cell/tissue type, treatment condition, and sample number. In the process of screening NCBI GEO/SRA data, all samples were manually verified according to the unique sample number to ensure that all sample data were unique and non-redundant. Ultimately, 542 publicly available human samples were collected from the four public data sources for this study. To ensure the quality of SE identification, each sample collected had to contain H3K27ac data and the INPUT data for the corresponding controls.</p>
    </sec>
    <sec id="sec4.2">
      <title>Global recognition of SEs and related genes in large samples</title>
      <p id="p0140">In this study, to ensure the accuracy and popularity of SE recognition, we used ROSE<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> to identify SEs in 542 human samples. We also completed the construction of a pipeline that mainly included sequence alignment, format conversion, H3K27ac peak identification, and SE identification. Based on these steps, this study identified 331,601 SEs and 1,992,738 SE elements in 542 samples.</p>
      <p id="p0145">Numerous studies have shown that calculating the read density of H3K27ac around transcription start sites can be used to estimate which genes are expressed in cells or tissues. In this study, <italic>CRC mapper</italic><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> was used to calculate the read density of H3K27ac in the ±1 kb region around the transcription start site (namely, the promoter region) of each transcript in each sample, and the gene transcripts were ranked according to the density. Then, the gene transcripts were assigned to the gene, and the duplicated genes were deleted. Finally, we obtained the closest active genes of the SE based on their proximity.</p>
    </sec>
    <sec id="sec4.3">
      <title>Systematic identification and evaluation of CRCs driven by SEs</title>
      <p id="p0150">To identify the CRCs, <italic>CRC mapper</italic><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> was used with sequence alignment data, the H3K27ac peaks identified by MACS,<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> and the enhancer output files from ROSE.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> The identification of CRCs was performed as follows: (1) using the results of SE regions and alignment results to calculate the closest active genes, (2) screening the part of the closest active genes that are TFs and find the TFs regulated by SEs, (3) TF motifs were collected from TRANSFAC<xref rid="bib60" ref-type="bibr"><sup>60</sup></xref> and JASPAR<xref rid="bib61" ref-type="bibr"><sup>61</sup></xref> databases, (4) FIMO in MEME<xref rid="bib62" ref-type="bibr"><sup>62</sup></xref> was used for motif scanning of the sequences of the SE elements. The scanning region of SE was limited to the SE elements and not all regions because such element regions were the binding regions of most TFs. The p value threshold of FIMO was 1 × 10<sup>−4</sup>, (5) a TF was defined as a self-regulatory TF when it could bind to an SE element that regulates the TF. Then, all the self-regulatory TFs bound to the SE of a sample were calculated, and the self-regulatory circuitry with complete interconnection of all the TFs was constructed using a recursive calculation, which was used as the model for all CRCs of the sample.</p>
      <p id="p0155">Many regulatory circuitries can be identified in a sample, and some studies have taken the most representative regulatory circuitry ranked first as the preferred CRC. However, a large number of studies have found that sometimes other regulatory circuitries not ranked first also play important roles. Therefore, in this study, all the regulatory circuitries identified by a sample were regarded as the CRCs of the sample, and they were integrated for analysis. After calculating the CRCs, the TFs composing them were defined as core TFs, which were all driven and regulated by SEs. Finally, 367,495 CRCs and 508 core TFs were successfully identified in 514 samples.</p>
      <p id="p0160">The other script used in this study to identify the CRCs was <italic>Coltron</italic> (<ext-link ext-link-type="uri" xlink:href="https://pypi.python.org/pypi/coltron" id="intref0030">https://pypi.python.org/pypi/coltron</ext-link>). Compared with <italic>CRC mapper</italic>, <italic>Coltron</italic> used sequence alignment data, H3K27ac valleys, and enhancer output files from ROSE. Another protocol was in line with “CRC mapper.” As a result, 8,235,853 CRCs and 541 core TFs were successfully identified in 483 samples.</p>
    </sec>
    <sec id="sec4.4">
      <title>Multi-omics data of core TFs</title>
      <p id="p0165">TF-related disease information was downloaded from DisGeNET.<xref rid="bib63" ref-type="bibr"><sup>63</sup></xref> TF gene expression data were downloaded from GTEx.<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> TF expression data across TCGA cancers were downloaded from UCSC Xena (<ext-link ext-link-type="uri" xlink:href="http://xena.ucsc.edu/" id="intref0035">http://xena.ucsc.edu/</ext-link>). H3K27ac, <italic>JUND</italic>, and <italic>AR</italic> ChIP-seq data from different tissues were downloaded from Cistrome and ENCODE databases.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> The clinical information of tumor patients, including their survival status, stage, grade, survival time, and response to chemotherapy, were downloaded from the TCGA project. ChIPseeker was performed to view the peak annotation distributions.<xref rid="bib64" ref-type="bibr"><sup>64</sup></xref> For genomic data, the variation information for core TFs was downloaded from cBioPortal (<ext-link ext-link-type="uri" xlink:href="http://cbioportal.org" id="intref0040">http://cbioportal.org</ext-link>).</p>
    </sec>
    <sec id="sec4.5">
      <title>Construction of common/tissue-specific CRC networks</title>
      <p id="p0170">In a given cell type, the core TFs in a CRC interconnected with each other, forming a fully connected network. All of the CRC networks identified by <italic>Coltron</italic> and <italic>CRC mapper</italic> are provided in <xref rid="mmc4" ref-type="supplementary-material">Tables S3</xref> and <xref rid="mmc5" ref-type="supplementary-material">S4</xref>. We listed the TF-TF interaction pairs of CRCs that appeared in different numbers of cell/tissue types. The pairs that appeared in more than 15 cell/tissue types were considered as common TF-TF interactions and integrated to construct a common CRC network. The pairs that only appeared in one cell/tissue type were considered as tissue-specific TF-TF interactions. Among them, heart-tissue-specific TF-TF interactions and prostate-tissue-specific TF-TF interactions were obtained to construct a heart-specific CRC network and a prostate-specific CRC network, respectively.</p>
      <p id="p0175">Based on the common CRC network, a fully connected module was located using CFinder software, which is a platform independent, stand-alone application that locates overlapping groups of densely interconnected nodes in graphs.<xref rid="bib65" ref-type="bibr"><sup>65</sup></xref></p>
    </sec>
    <sec id="sec4.6">
      <title>Function annotation</title>
      <p id="p0180">GO annotation and KEGG enrichment analyses were carried out using the R package, clusterProfiler.<xref rid="bib66" ref-type="bibr"><sup>66</sup></xref> Statistical significance was calculated using the hypergeometric test with p values less than 0.01.</p>
    </sec>
    <sec id="sec4.7">
      <title>Survival analysis</title>
      <p id="p0185">We constructed a Cox proportional hazards model, the interpretation of which was done using HR. HR was defined as the ratio of the predicted hazard function under two different values of a predictor variable.</p>
      <p id="p0190">The risk score for each patient was computed by the linear combination of the gene expression values weighted by the regression coefficient of the univariate Cox regression analysis, which was defined as follows:<disp-formula id="ufd1"><mml:math id="M1" altimg="si1.gif"><mml:mrow><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">k</mml:mi><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mrow><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi mathvariant="normal">i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi mathvariant="normal">n</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mspace width="0.25em"/><mml:mi>Exp</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="normal">i</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula></p>
      <p id="p0195">where r<sub>i</sub> is the Cox regression coefficient of gene i in the gene set, n is the number of genes in the gene set, and Exp(i) is the expression value of gene i in corresponding patient. The median risk score was used to classify patients into high-risk and low-risk groups.</p>
      <p id="p0200">Kaplan-Meier survival curves were plotted using the R survival package. Statistical significance was assessed using a two-tailed log rank test with a p value threshold of less than 0.01.</p>
    </sec>
    <sec id="sec4.8">
      <title>Immune cell infiltration of TFs in prostate cancer patients</title>
      <p id="p0205">Infiltration estimation scores for all cancer patients were downloaded from TIMER2.0,<xref rid="bib67" ref-type="bibr"><sup>67</sup></xref> which contained six immune cell infiltration levels. The potential roles of core TFs in cell infiltration were estimated by calculating the correlation between TF expression and the infiltration estimation scores.</p>
    </sec>
  </sec>
  <sec sec-type="data-availability" id="sec4.9">
    <title>Data availability</title>
    <p id="p0210">Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.</p>
  </sec>
</body>
<back>
  <ref-list id="cebib0010">
    <title>References</title>
    <ref id="bib1">
      <label>1</label>
      <element-citation publication-type="journal" id="sref1">
        <person-group person-group-type="author">
          <name>
            <surname>Lambert</surname>
            <given-names>S.A.</given-names>
          </name>
          <name>
            <surname>Jolma</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Campitelli</surname>
            <given-names>L.F.</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>P.K.</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Albu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Taipale</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Hughes</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Weirauch</surname>
            <given-names>M.T.</given-names>
          </name>
        </person-group>
        <article-title>The human transcription factors</article-title>
        <source>Cell</source>
        <volume>172</volume>
        <year>2018</year>
        <fpage>650</fpage>
        <lpage>665</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.029</pub-id>
        <pub-id pub-id-type="pmid">29425488</pub-id>
      </element-citation>
    </ref>
    <ref id="bib2">
      <label>2</label>
      <element-citation publication-type="journal" id="sref2">
        <person-group person-group-type="author">
          <name>
            <surname>Fuxman Bass</surname>
            <given-names>J.I.</given-names>
          </name>
          <name>
            <surname>Sahni</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Garcia-Gonzalez</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Vidal</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Walhout</surname>
            <given-names>A.J.M.</given-names>
          </name>
        </person-group>
        <article-title>Human gene-centered transcription factor networks for enhancers and disease variants</article-title>
        <source>Cell</source>
        <volume>161</volume>
        <year>2015</year>
        <fpage>661</fpage>
        <lpage>673</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2015.03.003</pub-id>
        <pub-id pub-id-type="pmid">25910213</pub-id>
      </element-citation>
    </ref>
    <ref id="bib3">
      <label>3</label>
      <element-citation publication-type="journal" id="sref3">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Plummer</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y.Y.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>T.C.</given-names>
          </name>
          <name>
            <surname>Gull</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>L.W.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma</article-title>
        <source>Gut</source>
        <volume>69</volume>
        <year>2020</year>
        <fpage>630</fpage>
        <lpage>640</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2019-318325</pub-id>
        <pub-id pub-id-type="pmid">31409603</pub-id>
      </element-citation>
    </ref>
    <ref id="bib4">
      <label>4</label>
      <element-citation publication-type="journal" id="sref4">
        <person-group person-group-type="author">
          <name>
            <surname>Boyer</surname>
            <given-names>L.A.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Cole</surname>
            <given-names>M.F.</given-names>
          </name>
          <name>
            <surname>Johnstone</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>S.S.</given-names>
          </name>
          <name>
            <surname>Zucker</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Guenther</surname>
            <given-names>M.G.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>H.L.</given-names>
          </name>
          <name>
            <surname>Jenner</surname>
            <given-names>R.G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Core transcriptional regulatory circuitry in human embryonic stem cells</article-title>
        <source>Cell</source>
        <volume>122</volume>
        <year>2005</year>
        <fpage>947</fpage>
        <lpage>956</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id>
        <pub-id pub-id-type="pmid">16153702</pub-id>
      </element-citation>
    </ref>
    <ref id="bib5">
      <label>5</label>
      <element-citation publication-type="journal" id="sref5">
        <person-group person-group-type="author">
          <name>
            <surname>Whyte</surname>
            <given-names>W.A.</given-names>
          </name>
          <name>
            <surname>Orlando</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Hnisz</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Kagey</surname>
            <given-names>M.H.</given-names>
          </name>
          <name>
            <surname>Rahl</surname>
            <given-names>P.B.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Master transcription factors and mediator establish super-enhancers at key cell identity genes</article-title>
        <source>Cell</source>
        <volume>153</volume>
        <year>2013</year>
        <fpage>307</fpage>
        <lpage>319</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.03.035</pub-id>
        <pub-id pub-id-type="pmid">23582322</pub-id>
      </element-citation>
    </ref>
    <ref id="bib6">
      <label>6</label>
      <element-citation publication-type="journal" id="sref6">
        <person-group person-group-type="author">
          <name>
            <surname>Durbin</surname>
            <given-names>A.D.</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>M.W.</given-names>
          </name>
          <name>
            <surname>Dharia</surname>
            <given-names>N.V.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Iniguez</surname>
            <given-names>A.B.</given-names>
          </name>
          <name>
            <surname>Weichert-Leahey</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Krill-Burger</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Root</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Vazquez</surname>
            <given-names>F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry</article-title>
        <source>Nat. Genet.</source>
        <volume>50</volume>
        <year>2018</year>
        <fpage>1240</fpage>
        <lpage>1246</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-018-0191-z</pub-id>
        <pub-id pub-id-type="pmid">30127528</pub-id>
      </element-citation>
    </ref>
    <ref id="bib7">
      <label>7</label>
      <element-citation publication-type="journal" id="sref7">
        <person-group person-group-type="author">
          <name>
            <surname>Ott</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Schwartz</surname>
            <given-names>L.S.</given-names>
          </name>
          <name>
            <surname>Kasar</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Klitgaard</surname>
            <given-names>J.L.</given-names>
          </name>
          <name>
            <surname>Lenci</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Lawlor</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Souza</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia</article-title>
        <source>Cancer Cell</source>
        <volume>34</volume>
        <year>2018</year>
        <fpage>982</fpage>
        <lpage>995.e7</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2018.11.001</pub-id>
        <pub-id pub-id-type="pmid">30503705</pub-id>
      </element-citation>
    </ref>
    <ref id="bib8">
      <label>8</label>
      <element-citation publication-type="journal" id="sref8">
        <person-group person-group-type="author">
          <name>
            <surname>Gryder</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Pomella</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sayers</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X.S.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Chiarella</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Bagchi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>H.C.</given-names>
          </name>
          <name>
            <surname>Sinniah</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Walton</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma</article-title>
        <source>Nat. Genet.</source>
        <volume>51</volume>
        <year>2019</year>
        <fpage>1714</fpage>
        <lpage>1722</lpage>
        <pub-id pub-id-type="doi">10.1038/s41588-019-0534-4</pub-id>
        <pub-id pub-id-type="pmid">31784732</pub-id>
      </element-citation>
    </ref>
    <ref id="bib9">
      <label>9</label>
      <element-citation publication-type="journal" id="sref9">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>Y.Y.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C.Q.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Dakle</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>J.W.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>R.Y.T.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>J.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TP63, SOX2, and KLF5 establish a core regulatory circuitry that controls epigenetic and transcription patterns in esophageal squamous cell carcinoma cell lines</article-title>
        <source>Gastroenterology</source>
        <volume>159</volume>
        <year>2020</year>
        <fpage>1311</fpage>
        <lpage>1327.e19</lpage>
        <pub-id pub-id-type="doi">10.1053/j.gastro.2020.06.050</pub-id>
        <pub-id pub-id-type="pmid">32619460</pub-id>
      </element-citation>
    </ref>
    <ref id="bib10">
      <label>10</label>
      <element-citation publication-type="journal" id="sref10">
        <person-group person-group-type="author">
          <name>
            <surname>Saint-André</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Reddy</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Bradner</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Models of human core transcriptional regulatory circuitries</article-title>
        <source>Genome Res.</source>
        <volume>26</volume>
        <year>2016</year>
        <fpage>385</fpage>
        <lpage>396</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.197590.115</pub-id>
        <pub-id pub-id-type="pmid">26843070</pub-id>
      </element-citation>
    </ref>
    <ref id="bib11">
      <label>11</label>
      <element-citation publication-type="journal" id="sref11">
        <person-group person-group-type="author">
          <name>
            <surname>Aldiri</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Hiler</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Griffiths</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Valentine</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Shirinifard</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Thiagarajan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sablauer</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
          <collab>St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project</collab>
        </person-group>
        <article-title>The dynamic epigenetic landscape of the retina during development, reprogramming, and tumorigenesis</article-title>
        <source>Neuron</source>
        <volume>94</volume>
        <year>2017</year>
        <fpage>550</fpage>
        <lpage>568.e10</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neuron.2017.04.022</pub-id>
        <pub-id pub-id-type="pmid">28472656</pub-id>
      </element-citation>
    </ref>
    <ref id="bib12">
      <label>12</label>
      <element-citation publication-type="journal" id="sref12">
        <person-group person-group-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Erkek</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Federation</surname>
            <given-names>A.J.</given-names>
          </name>
          <name>
            <surname>Zapatka</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Haldipur</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Kawauchi</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Risch</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Warnatz</surname>
            <given-names>H.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Active medulloblastoma enhancers reveal subgroup-specific cellular origins</article-title>
        <source>Nature</source>
        <volume>530</volume>
        <year>2016</year>
        <fpage>57</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1038/nature16546</pub-id>
        <pub-id pub-id-type="pmid">26814967</pub-id>
      </element-citation>
    </ref>
    <ref id="bib13">
      <label>13</label>
      <element-citation publication-type="journal" id="sref13">
        <person-group person-group-type="author">
          <name>
            <surname>Grandi</surname>
            <given-names>F.C.</given-names>
          </name>
          <name>
            <surname>Modi</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Kampman</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Corces</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Chromatin accessibility profiling by ATAC-seq</article-title>
        <source>Nat. Protoc.</source>
        <volume>17</volume>
        <year>2022</year>
        <fpage>1518</fpage>
        <lpage>1552</lpage>
        <pub-id pub-id-type="doi">10.1038/s41596-022-00692-9</pub-id>
        <pub-id pub-id-type="pmid">35478247</pub-id>
      </element-citation>
    </ref>
    <ref id="bib14">
      <label>14</label>
      <element-citation publication-type="journal" id="sref14">
        <person-group person-group-type="author">
          <name>
            <surname>Barrett</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Troup</surname>
            <given-names>D.B.</given-names>
          </name>
          <name>
            <surname>Wilhite</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Ledoux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Evangelista</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>I.F.</given-names>
          </name>
          <name>
            <surname>Tomashevsky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Marshall</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Phillippy</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Sherman</surname>
            <given-names>P.M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NCBI GEO: archive for functional genomics data sets--10 years on</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>39</volume>
        <year>2011</year>
        <fpage>D1005</fpage>
        <lpage>D1010</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1184</pub-id>
        <pub-id pub-id-type="pmid">21097893</pub-id>
      </element-citation>
    </ref>
    <ref id="bib15">
      <label>15</label>
      <element-citation publication-type="journal" id="sref15">
        <person-group person-group-type="author">
          <collab>ENCODE Project Consortium</collab>
        </person-group>
        <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
        <source>Nature</source>
        <volume>489</volume>
        <year>2012</year>
        <fpage>57</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
        <pub-id pub-id-type="pmid">22955616</pub-id>
      </element-citation>
    </ref>
    <ref id="bib16">
      <label>16</label>
      <element-citation publication-type="journal" id="sref16">
        <person-group person-group-type="author">
          <collab>Roadmap Epigenomics Consortium</collab>
          <name>
            <surname>Kundaje</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Meuleman</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Ernst</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bilenky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Heravi-Moussavi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kheradpour</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative analysis of 111 reference human epigenomes</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>317</fpage>
        <lpage>330</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14248</pub-id>
        <pub-id pub-id-type="pmid">25693563</pub-id>
      </element-citation>
    </ref>
    <ref id="bib17">
      <label>17</label>
      <element-citation publication-type="journal" id="sref17">
        <person-group person-group-type="author">
          <name>
            <surname>Bièche</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Lerebours</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Tozlu</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Espie</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Marty</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lidereau</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature</article-title>
        <source>Clin. Cancer Res.</source>
        <volume>10</volume>
        <year>2004</year>
        <fpage>6789</fpage>
        <lpage>6795</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0306</pub-id>
        <pub-id pub-id-type="pmid">15501955</pub-id>
      </element-citation>
    </ref>
    <ref id="bib18">
      <label>18</label>
      <element-citation publication-type="journal" id="sref18">
        <person-group person-group-type="author">
          <name>
            <surname>Jennings</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Quinn</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ly</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Rehman</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Orthopaedic surgery resident financial literacy: an assessment of knowledge in debt, investment, and retirement savings</article-title>
        <source>Am. Surg.</source>
        <volume>85</volume>
        <year>2019</year>
        <fpage>353</fpage>
        <lpage>358</lpage>
        <pub-id pub-id-type="pmid">31043194</pub-id>
      </element-citation>
    </ref>
    <ref id="bib19">
      <label>19</label>
      <element-citation publication-type="journal" id="sref19">
        <person-group person-group-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xi</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>High expression of kruppel-like factor 7 indicates unfavorable clinical outcomes in patients with lung adenocarcinoma</article-title>
        <source>J. Surg. Res.</source>
        <volume>250</volume>
        <year>2020</year>
        <fpage>216</fpage>
        <lpage>223</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jss.2019.12.053</pub-id>
        <pub-id pub-id-type="pmid">32092599</pub-id>
      </element-citation>
    </ref>
    <ref id="bib20">
      <label>20</label>
      <element-citation publication-type="journal" id="sref20">
        <person-group person-group-type="author">
          <name>
            <surname>Xiang</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Xiong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>C.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tumor suppressive BTB/POZ zinc-finger protein ZBTB28 inhibits oncogenic BCL6/ZBTB27 signaling to maintain p53 transcription in multiple carcinogenesis</article-title>
        <source>Theranostics</source>
        <volume>9</volume>
        <year>2019</year>
        <fpage>8182</fpage>
        <lpage>8195</lpage>
        <pub-id pub-id-type="doi">10.7150/thno.34983</pub-id>
        <pub-id pub-id-type="pmid">31754389</pub-id>
      </element-citation>
    </ref>
    <ref id="bib21">
      <label>21</label>
      <element-citation publication-type="journal" id="sref21">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S.H.</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>H.I.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Binas</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>K.S.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>Y.S.</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>Y.G.</given-names>
          </name>
        </person-group>
        <article-title>Forkhead box O1 (FOXO1) controls the migratory response of Toll-like receptor (TLR3)-stimulated human mesenchymal stromal cells</article-title>
        <source>J. Biol. Chem.</source>
        <volume>294</volume>
        <year>2019</year>
        <fpage>8424</fpage>
        <lpage>8437</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.RA119.008673</pub-id>
        <pub-id pub-id-type="pmid">30944148</pub-id>
      </element-citation>
    </ref>
    <ref id="bib22">
      <label>22</label>
      <element-citation publication-type="journal" id="sref22">
        <person-group person-group-type="author">
          <name>
            <surname>Ferrari</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Mohammed</surname>
            <given-names>Z.M.A.</given-names>
          </name>
          <name>
            <surname>Nixon</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Mason</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Mallon</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>McMillan</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Cameron</surname>
            <given-names>E.R.</given-names>
          </name>
          <name>
            <surname>Edwards</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Blyth</surname>
            <given-names>K.</given-names>
          </name>
        </person-group>
        <article-title>Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer</article-title>
        <source>PLoS One</source>
        <volume>9</volume>
        <year>2014</year>
        <fpage>e100759</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0100759</pub-id>
        <pub-id pub-id-type="pmid">24967588</pub-id>
      </element-citation>
    </ref>
    <ref id="bib23">
      <label>23</label>
      <element-citation publication-type="journal" id="sref23">
        <person-group person-group-type="author">
          <name>
            <surname>Godini</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Fallahi</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Dynamics changes in the transcription factors during early human embryonic development</article-title>
        <source>J. Cell. Physiol.</source>
        <volume>234</volume>
        <year>2019</year>
        <fpage>6489</fpage>
        <lpage>6502</lpage>
        <pub-id pub-id-type="doi">10.1002/jcp.27386</pub-id>
        <pub-id pub-id-type="pmid">30246428</pub-id>
      </element-citation>
    </ref>
    <ref id="bib24">
      <label>24</label>
      <element-citation publication-type="journal" id="sref24">
        <person-group person-group-type="author">
          <name>
            <surname>Litvinov</surname>
            <given-names>I.V.</given-names>
          </name>
          <name>
            <surname>Vander Griend</surname>
            <given-names>D.J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Antony</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Dalrymple</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Isaacs</surname>
            <given-names>J.T.</given-names>
          </name>
        </person-group>
        <article-title>Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells</article-title>
        <source>Cancer Res.</source>
        <volume>66</volume>
        <year>2006</year>
        <fpage>8598</fpage>
        <lpage>8607</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-1228</pub-id>
        <pub-id pub-id-type="pmid">16951173</pub-id>
      </element-citation>
    </ref>
    <ref id="bib25">
      <label>25</label>
      <element-citation publication-type="journal" id="sref25">
        <person-group person-group-type="author">
          <name>
            <surname>Neou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Villa</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Armignacco</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jouinot</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Raffin-Sanson</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Septier</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Letourneur</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Diry</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Diedisheim</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Izac</surname>
            <given-names>B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Pangenomic classification of pituitary neuroendocrine tumors</article-title>
        <source>Cancer Cell</source>
        <volume>37</volume>
        <year>2020</year>
        <fpage>123</fpage>
        <lpage>134.e5</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ccell.2019.11.002</pub-id>
        <pub-id pub-id-type="pmid">31883967</pub-id>
      </element-citation>
    </ref>
    <ref id="bib26">
      <label>26</label>
      <element-citation publication-type="journal" id="sref26">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Shox2 regulates osteogenic differentiation and pattern formation during hard palate development in mice</article-title>
        <source>J. Biol. Chem.</source>
        <volume>294</volume>
        <year>2019</year>
        <fpage>18294</fpage>
        <lpage>18305</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.RA119.008801</pub-id>
        <pub-id pub-id-type="pmid">31649032</pub-id>
      </element-citation>
    </ref>
    <ref id="bib27">
      <label>27</label>
      <element-citation publication-type="journal" id="sref27">
        <person-group person-group-type="author">
          <name>
            <surname>Clarke</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ballios</surname>
            <given-names>B.G.</given-names>
          </name>
          <name>
            <surname>van der Kooy</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Generation and clonal isolation of retinal stem cells from human embryonic stem cells</article-title>
        <source>Eur. J. Neurosci.</source>
        <volume>36</volume>
        <year>2012</year>
        <fpage>1951</fpage>
        <lpage>1959</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08123.x</pub-id>
        <pub-id pub-id-type="pmid">22591375</pub-id>
      </element-citation>
    </ref>
    <ref id="bib28">
      <label>28</label>
      <element-citation publication-type="journal" id="sref28">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Ai</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TF-Marker: a comprehensive manually curated database for transcription factors and related markers in specific cell and tissue types in human</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>50</volume>
        <year>2022</year>
        <fpage>D402</fpage>
        <lpage>D412</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab1114</pub-id>
        <pub-id pub-id-type="pmid">34986601</pub-id>
      </element-citation>
    </ref>
    <ref id="bib29">
      <label>29</label>
      <element-citation publication-type="journal" id="sref29">
        <person-group person-group-type="author">
          <name>
            <surname>Hnisz</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Saint-André</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Sigova</surname>
            <given-names>A.A.</given-names>
          </name>
          <name>
            <surname>Hoke</surname>
            <given-names>H.A.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Super-enhancers in the control of cell identity and disease</article-title>
        <source>Cell</source>
        <volume>155</volume>
        <year>2013</year>
        <fpage>934</fpage>
        <lpage>947</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.09.053</pub-id>
        <pub-id pub-id-type="pmid">24119843</pub-id>
      </element-citation>
    </ref>
    <ref id="bib30">
      <label>30</label>
      <element-citation publication-type="journal" id="sref30">
        <person-group person-group-type="author">
          <collab>GTEx Consortium</collab>
        </person-group>
        <article-title>The genotype-tissue expression (GTEx) project</article-title>
        <source>Nat. Genet.</source>
        <volume>45</volume>
        <year>2013</year>
        <fpage>580</fpage>
        <lpage>585</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2653</pub-id>
        <pub-id pub-id-type="pmid">23715323</pub-id>
      </element-citation>
    </ref>
    <ref id="bib31">
      <label>31</label>
      <element-citation publication-type="journal" id="sref31">
        <person-group person-group-type="author">
          <name>
            <surname>Ajayi-Smith</surname>
            <given-names>A.F.</given-names>
          </name>
          <name>
            <surname>van der Watt</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Leaner</surname>
            <given-names>V.D.</given-names>
          </name>
        </person-group>
        <article-title>Interfering with nuclear transport as a means of interrupting transcription factor activity in cancer</article-title>
        <source>Crit. Rev. Eukaryot. Gene Expr.</source>
        <volume>29</volume>
        <year>2019</year>
        <fpage>413</fpage>
        <lpage>424</lpage>
        <pub-id pub-id-type="doi">10.1615/CritRevEukaryotGeneExpr.2019026309</pub-id>
        <pub-id pub-id-type="pmid">32421998</pub-id>
      </element-citation>
    </ref>
    <ref id="bib32">
      <label>32</label>
      <element-citation publication-type="journal" id="sref32">
        <person-group person-group-type="author">
          <name>
            <surname>Nimura</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Takeichi</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Saga</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Takaoka</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kawamura</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Nitta</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Nagano</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Ishino</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>T.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Regulation of alternative polyadenylation by Nkx2-5 and Xrn2 during mouse heart development</article-title>
        <source>Elife</source>
        <volume>5</volume>
        <year>2016</year>
        <fpage>e16030</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.16030</pub-id>
        <pub-id pub-id-type="pmid">27331609</pub-id>
      </element-citation>
    </ref>
    <ref id="bib33">
      <label>33</label>
      <element-citation publication-type="journal" id="sref33">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B.Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>The role of Tbx20 in cardiovascular development and function</article-title>
        <source>Front. Cell Dev. Biol.</source>
        <volume>9</volume>
        <year>2021</year>
        <fpage>638542</fpage>
        <pub-id pub-id-type="doi">10.3389/fcell.2021.638542</pub-id>
        <pub-id pub-id-type="pmid">33585493</pub-id>
      </element-citation>
    </ref>
    <ref id="bib34">
      <label>34</label>
      <element-citation publication-type="journal" id="sref34">
        <person-group person-group-type="author">
          <name>
            <surname>Butler</surname>
            <given-names>L.M.</given-names>
          </name>
          <name>
            <surname>Centenera</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Swinnen</surname>
            <given-names>J.V.</given-names>
          </name>
        </person-group>
        <article-title>Androgen control of lipid metabolism in prostate cancer: novel insights and future applications</article-title>
        <source>Endocr. Relat. Cancer</source>
        <volume>23</volume>
        <year>2016</year>
        <fpage>R219</fpage>
        <lpage>R227</lpage>
        <pub-id pub-id-type="doi">10.1530/ERC-15-0556</pub-id>
        <pub-id pub-id-type="pmid">27130044</pub-id>
      </element-citation>
    </ref>
    <ref id="bib35">
      <label>35</label>
      <element-citation publication-type="journal" id="sref35">
        <person-group person-group-type="author">
          <name>
            <surname>Edwards</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Flohr</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Shipley</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Giddings</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Te-Poele</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Dodson</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Foster</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Jhavar</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer</article-title>
        <source>Br. J. Cancer</source>
        <volume>92</volume>
        <year>2005</year>
        <fpage>376</fpage>
        <lpage>381</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.bjc.6602261</pub-id>
        <pub-id pub-id-type="pmid">15583692</pub-id>
      </element-citation>
    </ref>
    <ref id="bib36">
      <label>36</label>
      <element-citation publication-type="journal" id="sref36">
        <person-group person-group-type="author">
          <name>
            <surname>Economides</surname>
            <given-names>K.D.</given-names>
          </name>
          <name>
            <surname>Capecchi</surname>
            <given-names>M.R.</given-names>
          </name>
        </person-group>
        <article-title>Hoxb13 is required for normal differentiation and secretory function of the ventral prostate</article-title>
        <source>Development</source>
        <volume>130</volume>
        <year>2003</year>
        <fpage>2061</fpage>
        <lpage>2069</lpage>
        <pub-id pub-id-type="doi">10.1242/dev.00432</pub-id>
        <pub-id pub-id-type="pmid">12668621</pub-id>
      </element-citation>
    </ref>
    <ref id="bib37">
      <label>37</label>
      <element-citation publication-type="journal" id="sref37">
        <person-group person-group-type="author">
          <name>
            <surname>Thiele</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Varus</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Wickenhauser</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kvasnicka</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Metz</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Beelen</surname>
            <given-names>D.W.</given-names>
          </name>
        </person-group>
        <article-title>Regeneration of heart muscle tissue: quantification of chimeric cardiomyocytes and endothelial cells following transplantation</article-title>
        <source>Histol. Histopathol.</source>
        <volume>19</volume>
        <year>2004</year>
        <fpage>201</fpage>
        <lpage>209</lpage>
        <pub-id pub-id-type="doi">10.14670/HH-19.201</pub-id>
        <pub-id pub-id-type="pmid">14702188</pub-id>
      </element-citation>
    </ref>
    <ref id="bib38">
      <label>38</label>
      <element-citation publication-type="journal" id="sref38">
        <person-group person-group-type="author">
          <name>
            <surname>McLean</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Bristor</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Hiller</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Clarke</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Schaar</surname>
            <given-names>B.T.</given-names>
          </name>
          <name>
            <surname>Lowe</surname>
            <given-names>C.B.</given-names>
          </name>
          <name>
            <surname>Wenger</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Bejerano</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title>
        <source>Nat. Biotechnol.</source>
        <volume>28</volume>
        <year>2010</year>
        <fpage>495</fpage>
        <lpage>501</lpage>
        <pub-id pub-id-type="doi">10.1038/nbt.1630</pub-id>
        <pub-id pub-id-type="pmid">20436461</pub-id>
      </element-citation>
    </ref>
    <ref id="bib39">
      <label>39</label>
      <element-citation publication-type="journal" id="sref39">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy</article-title>
        <source>EBioMedicine</source>
        <volume>83</volume>
        <year>2022</year>
        <fpage>104207</fpage>
        <pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104207</pub-id>
        <pub-id pub-id-type="pmid">35961204</pub-id>
      </element-citation>
    </ref>
    <ref id="bib40">
      <label>40</label>
      <element-citation publication-type="journal" id="sref40">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Immuno-genomic characterisation of high-grade serous ovarian cancer reveals immune evasion mechanisms and identifies an immunological subtype with a favourable prognosis and improved therapeutic efficacy</article-title>
        <source>Br. J. Cancer</source>
        <volume>126</volume>
        <year>2022</year>
        <fpage>1570</fpage>
        <lpage>1580</lpage>
        <pub-id pub-id-type="doi">10.1038/s41416-021-01692-4</pub-id>
        <pub-id pub-id-type="pmid">35017656</pub-id>
      </element-citation>
    </ref>
    <ref id="bib41">
      <label>41</label>
      <element-citation publication-type="journal" id="sref41">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer</article-title>
        <source>J. Immunother. Cancer</source>
        <volume>8</volume>
        <year>2020</year>
        <fpage>e000110</fpage>
        <pub-id pub-id-type="doi">10.1136/jitc-2019-000110</pub-id>
        <pub-id pub-id-type="pmid">32041817</pub-id>
      </element-citation>
    </ref>
    <ref id="bib42">
      <label>42</label>
      <element-citation publication-type="journal" id="sref42">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer</article-title>
        <source>Brief. Bioinform.</source>
        <volume>22</volume>
        <year>2021</year>
        <fpage>bbaa047</fpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbaa047</pub-id>
        <pub-id pub-id-type="pmid">32382761</pub-id>
      </element-citation>
    </ref>
    <ref id="bib43">
      <label>43</label>
      <element-citation publication-type="journal" id="sref43">
        <person-group person-group-type="author">
          <name>
            <surname>Cha</surname>
            <given-names>H.R.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>J.H.</given-names>
          </name>
          <name>
            <surname>Ponnazhagan</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Revisiting immunotherapy: a focus on prostate cancer</article-title>
        <source>Cancer Res.</source>
        <volume>80</volume>
        <year>2020</year>
        <fpage>1615</fpage>
        <lpage>1623</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-2948</pub-id>
        <pub-id pub-id-type="pmid">32066566</pub-id>
      </element-citation>
    </ref>
    <ref id="bib44">
      <label>44</label>
      <element-citation publication-type="journal" id="sref44">
        <person-group person-group-type="author">
          <name>
            <surname>Guan</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Polesso</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Sehrawat</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hawkins</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>S.E.</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>G.V.</given-names>
          </name>
          <name>
            <surname>Caruso</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>R.F.</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>M.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Androgen receptor activity in T cells limits checkpoint blockade efficacy</article-title>
        <source>Nature</source>
        <volume>606</volume>
        <year>2022</year>
        <fpage>791</fpage>
        <lpage>796</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-022-04522-6</pub-id>
        <pub-id pub-id-type="pmid">35322234</pub-id>
      </element-citation>
    </ref>
    <ref id="bib45">
      <label>45</label>
      <element-citation publication-type="journal" id="sref45">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity</article-title>
        <source>Immunity</source>
        <volume>55</volume>
        <year>2022</year>
        <fpage>1268</fpage>
        <lpage>1283.e9</lpage>
        <pub-id pub-id-type="doi">10.1016/j.immuni.2022.05.012</pub-id>
        <pub-id pub-id-type="pmid">35700739</pub-id>
      </element-citation>
    </ref>
    <ref id="bib46">
      <label>46</label>
      <element-citation publication-type="journal" id="sref46">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>X.H.</given-names>
          </name>
          <name>
            <surname>Black</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Ustiyan</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fulford</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sridharan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Medvedovic</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kalinichenko</surname>
            <given-names>V.V.</given-names>
          </name>
          <name>
            <surname>Whitsett</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Kalin</surname>
            <given-names>T.V.</given-names>
          </name>
        </person-group>
        <article-title>SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene</article-title>
        <source>PLoS Genet.</source>
        <volume>10</volume>
        <year>2014</year>
        <fpage>e1004656</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1004656</pub-id>
        <pub-id pub-id-type="pmid">25254494</pub-id>
      </element-citation>
    </ref>
    <ref id="bib47">
      <label>47</label>
      <element-citation publication-type="journal" id="sref47">
        <person-group person-group-type="author">
          <name>
            <surname>Korfhagen</surname>
            <given-names>T.R.</given-names>
          </name>
          <name>
            <surname>Kitzmiller</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Sridharan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Haitchi</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Hegde</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Divanovic</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Karp</surname>
            <given-names>C.L.</given-names>
          </name>
          <name>
            <surname>Whitsett</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <volume>109</volume>
        <year>2012</year>
        <fpage>16630</fpage>
        <lpage>16635</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1208092109</pub-id>
        <pub-id pub-id-type="pmid">23012424</pub-id>
      </element-citation>
    </ref>
    <ref id="bib48">
      <label>48</label>
      <element-citation publication-type="journal" id="sref48">
        <person-group person-group-type="author">
          <name>
            <surname>Riazi</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Van Arsdell</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>CSX/Nkx2.5 modulates differentiation of skeletal myoblasts and promotes differentiation into neuronal cells in vitro</article-title>
        <source>J. Biol. Chem.</source>
        <volume>280</volume>
        <year>2005</year>
        <fpage>10716</fpage>
        <lpage>10720</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M500028200</pub-id>
        <pub-id pub-id-type="pmid">15653675</pub-id>
      </element-citation>
    </ref>
    <ref id="bib49">
      <label>49</label>
      <element-citation publication-type="journal" id="sref49">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Santostefano</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Terada</surname>
            <given-names>N.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enhanced differentiation of human pluripotent stem cells into cardiomyocytes by bacteria-mediated transcription factors delivery</article-title>
        <source>PLoS One</source>
        <volume>13</volume>
        <year>2018</year>
        <fpage>e0194895</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0194895</pub-id>
        <pub-id pub-id-type="pmid">29579079</pub-id>
      </element-citation>
    </ref>
    <ref id="bib50">
      <label>50</label>
      <element-citation publication-type="journal" id="sref50">
        <person-group person-group-type="author">
          <name>
            <surname>Vincentz</surname>
            <given-names>J.W.</given-names>
          </name>
          <name>
            <surname>Barnes</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Firulli</surname>
            <given-names>B.A.</given-names>
          </name>
          <name>
            <surname>Conway</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Firulli</surname>
            <given-names>A.B.</given-names>
          </name>
        </person-group>
        <article-title>Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart development</article-title>
        <source>Dev. Dyn.</source>
        <volume>237</volume>
        <year>2008</year>
        <fpage>3809</fpage>
        <lpage>3819</lpage>
        <pub-id pub-id-type="doi">10.1002/dvdy.21803</pub-id>
        <pub-id pub-id-type="pmid">19035347</pub-id>
      </element-citation>
    </ref>
    <ref id="bib51">
      <label>51</label>
      <element-citation publication-type="journal" id="sref51">
        <person-group person-group-type="author">
          <name>
            <surname>Ziller</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Edri</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Yaffe</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Donaghey</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pop</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Mallard</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Issner</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Gifford</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Goren</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dissecting neural differentiation regulatory networks through epigenetic footprinting</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>355</fpage>
        <lpage>359</lpage>
        <pub-id pub-id-type="doi">10.1038/nature13990</pub-id>
        <pub-id pub-id-type="pmid">25533951</pub-id>
      </element-citation>
    </ref>
    <ref id="bib52">
      <label>52</label>
      <element-citation publication-type="journal" id="sref52">
        <person-group person-group-type="author">
          <name>
            <surname>Dixon</surname>
            <given-names>J.R.</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Selvaraj</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Antosiewicz-Bourget</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A.Y.</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Rajagopal</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>W.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Chromatin architecture reorganization during stem cell differentiation</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>331</fpage>
        <lpage>336</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14222</pub-id>
        <pub-id pub-id-type="pmid">25693564</pub-id>
      </element-citation>
    </ref>
    <ref id="bib53">
      <label>53</label>
      <element-citation publication-type="journal" id="sref53">
        <person-group person-group-type="author">
          <name>
            <surname>Tsankov</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Akopian</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Ziller</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Donaghey</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Amit</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Gnirke</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Meissner</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Transcription factor binding dynamics during human ES cell differentiation</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>344</fpage>
        <lpage>349</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14233</pub-id>
        <pub-id pub-id-type="pmid">25693565</pub-id>
      </element-citation>
    </ref>
    <ref id="bib54">
      <label>54</label>
      <element-citation publication-type="journal" id="sref54">
        <person-group person-group-type="author">
          <name>
            <surname>Neph</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Stergachis</surname>
            <given-names>A.B.</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Borenstein</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Stamatoyannopoulos</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Circuitry and dynamics of human transcription factor regulatory networks</article-title>
        <source>Cell</source>
        <volume>150</volume>
        <year>2012</year>
        <fpage>1274</fpage>
        <lpage>1286</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2012.04.040</pub-id>
        <pub-id pub-id-type="pmid">22959076</pub-id>
      </element-citation>
    </ref>
    <ref id="bib55">
      <label>55</label>
      <element-citation publication-type="journal" id="sref55">
        <person-group person-group-type="author">
          <name>
            <surname>Novershtern</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Lawton</surname>
            <given-names>L.N.</given-names>
          </name>
          <name>
            <surname>Mak</surname>
            <given-names>R.H.</given-names>
          </name>
          <name>
            <surname>Haining</surname>
            <given-names>W.N.</given-names>
          </name>
          <name>
            <surname>McConkey</surname>
            <given-names>M.E.</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Yosef</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Shay</surname>
            <given-names>T.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Densely interconnected transcriptional circuits control cell states in human hematopoiesis</article-title>
        <source>Cell</source>
        <volume>144</volume>
        <year>2011</year>
        <fpage>296</fpage>
        <lpage>309</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2011.01.004</pub-id>
        <pub-id pub-id-type="pmid">21241896</pub-id>
      </element-citation>
    </ref>
    <ref id="bib56">
      <label>56</label>
      <element-citation publication-type="journal" id="sref56">
        <person-group person-group-type="author">
          <name>
            <surname>Huynh-Thu</surname>
            <given-names>V.A.</given-names>
          </name>
          <name>
            <surname>Irrthum</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Wehenkel</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Geurts</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>Inferring regulatory networks from expression data using tree-based methods</article-title>
        <source>PLoS One</source>
        <volume>5</volume>
        <year>2010</year>
        <fpage>e12776</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0012776</pub-id>
        <pub-id pub-id-type="pmid">20927193</pub-id>
      </element-citation>
    </ref>
    <ref id="bib57">
      <label>57</label>
      <element-citation publication-type="journal" id="sref57">
        <person-group person-group-type="author">
          <name>
            <surname>Margolin</surname>
            <given-names>A.A.</given-names>
          </name>
          <name>
            <surname>Nemenman</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Basso</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Wiggins</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Stolovitzky</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Dalla Favera</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Califano</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>
        <source>BMC Bioinformatics</source>
        <volume>7</volume>
        <year>2006</year>
        <fpage>S7</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-7-S1-S7</pub-id>
      </element-citation>
    </ref>
    <ref id="bib58">
      <label>58</label>
      <element-citation publication-type="journal" id="sref58">
        <person-group person-group-type="author">
          <name>
            <surname>Lovén</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Hoke</surname>
            <given-names>H.A.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Orlando</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Vakoc</surname>
            <given-names>C.R.</given-names>
          </name>
          <name>
            <surname>Bradner</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>T.I.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>R.A.</given-names>
          </name>
        </person-group>
        <article-title>Selective inhibition of tumor oncogenes by disruption of super-enhancers</article-title>
        <source>Cell</source>
        <volume>153</volume>
        <year>2013</year>
        <fpage>320</fpage>
        <lpage>334</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2013.03.036</pub-id>
        <pub-id pub-id-type="pmid">23582323</pub-id>
      </element-citation>
    </ref>
    <ref id="bib59">
      <label>59</label>
      <element-citation publication-type="journal" id="sref59">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Eeckhoute</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D.S.</given-names>
          </name>
          <name>
            <surname>Bernstein</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Nusbaum</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.S.</given-names>
          </name>
        </person-group>
        <article-title>Model-based analysis of ChIP-seq (MACS)</article-title>
        <source>Genome Biol.</source>
        <volume>9</volume>
        <year>2008</year>
        <fpage>R137</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id>
        <pub-id pub-id-type="pmid">18798982</pub-id>
      </element-citation>
    </ref>
    <ref id="bib60">
      <label>60</label>
      <element-citation publication-type="journal" id="sref60">
        <person-group person-group-type="author">
          <name>
            <surname>Matys</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Kel-Margoulis</surname>
            <given-names>O.V.</given-names>
          </name>
          <name>
            <surname>Fricke</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Liebich</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Land</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Barre-Dirrie</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Reuter</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Chekmenev</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Krull</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Hornischer</surname>
            <given-names>K.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>34</volume>
        <year>2006</year>
        <fpage>D108</fpage>
        <lpage>D110</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkj143</pub-id>
        <pub-id pub-id-type="pmid">16381825</pub-id>
      </element-citation>
    </ref>
    <ref id="bib61">
      <label>61</label>
      <element-citation publication-type="journal" id="sref61">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Fornes</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Stigliani</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Gheorghe</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Castro-Mondragon</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>van der Lee</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Bessy</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chèneby</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kulkarni</surname>
            <given-names>S.R.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>46</volume>
        <year>2018</year>
        <fpage>D260</fpage>
        <lpage>D266</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1126</pub-id>
        <pub-id pub-id-type="pmid">29140473</pub-id>
      </element-citation>
    </ref>
    <ref id="bib62">
      <label>62</label>
      <element-citation publication-type="journal" id="sref62">
        <person-group person-group-type="author">
          <name>
            <surname>Bailey</surname>
            <given-names>T.L.</given-names>
          </name>
          <name>
            <surname>Boden</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Buske</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Frith</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>C.E.</given-names>
          </name>
          <name>
            <surname>Clementi</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W.W.</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>W.S.</given-names>
          </name>
        </person-group>
        <article-title>MEME SUITE: tools for motif discovery and searching</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>37</volume>
        <year>2009</year>
        <fpage>W202</fpage>
        <lpage>W208</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkp335</pub-id>
        <pub-id pub-id-type="pmid">19458158</pub-id>
      </element-citation>
    </ref>
    <ref id="bib63">
      <label>63</label>
      <element-citation publication-type="journal" id="sref63">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bravo</surname>
            <given-names>À.</given-names>
          </name>
          <name>
            <surname>Queralt-Rosinach</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Gutiérrez-Sacristán</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Deu-Pons</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Centeno</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>García-García</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sanz</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Furlong</surname>
            <given-names>L.I.</given-names>
          </name>
        </person-group>
        <article-title>DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>45</volume>
        <year>2017</year>
        <fpage>D833</fpage>
        <lpage>D839</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw943</pub-id>
        <pub-id pub-id-type="pmid">27924018</pub-id>
      </element-citation>
    </ref>
    <ref id="bib64">
      <label>64</label>
      <element-citation publication-type="journal" id="sref64">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Q.Y.</given-names>
          </name>
        </person-group>
        <article-title>ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title>
        <source>Bioinformatics</source>
        <volume>31</volume>
        <year>2015</year>
        <fpage>2382</fpage>
        <lpage>2383</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btv145</pub-id>
        <pub-id pub-id-type="pmid">25765347</pub-id>
      </element-citation>
    </ref>
    <ref id="bib65">
      <label>65</label>
      <element-citation publication-type="journal" id="sref65">
        <person-group person-group-type="author">
          <name>
            <surname>Adamcsek</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Palla</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Farkas</surname>
            <given-names>I.J.</given-names>
          </name>
          <name>
            <surname>Derényi</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Vicsek</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>CFinder: locating cliques and overlapping modules in biological networks</article-title>
        <source>Bioinformatics</source>
        <volume>22</volume>
        <year>2006</year>
        <fpage>1021</fpage>
        <lpage>1023</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl039</pub-id>
        <pub-id pub-id-type="pmid">16473872</pub-id>
      </element-citation>
    </ref>
    <ref id="bib66">
      <label>66</label>
      <element-citation publication-type="journal" id="sref66">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Q.Y.</given-names>
          </name>
        </person-group>
        <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
        <source>OMICS</source>
        <volume>16</volume>
        <year>2012</year>
        <fpage>284</fpage>
        <lpage>287</lpage>
        <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
        <pub-id pub-id-type="pmid">22455463</pub-id>
      </element-citation>
    </ref>
    <ref id="bib67">
      <label>67</label>
      <element-citation publication-type="journal" id="sref67">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.S.</given-names>
          </name>
        </person-group>
        <article-title>TIMER2.0 for analysis of tumor-infiltrating immune cells</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>48</volume>
        <year>2020</year>
        <fpage>W509</fpage>
        <lpage>W514</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa407</pub-id>
        <pub-id pub-id-type="pmid">32442275</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="appsec2" sec-type="supplementary-material">
    <title>Supplemental information</title>
    <p id="p0235">
      <supplementary-material content-type="local-data" id="mmc1">
        <caption>
          <title>Document S1. Figures S1 and S2</title>
        </caption>
        <media xlink:href="mmc1.pdf"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc2">
        <caption>
          <title>Table S1. All the samples of CRCs in more than 50 cell/tissue types</title>
        </caption>
        <media xlink:href="mmc2.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc3">
        <caption>
          <title>Table S2. The specific and overlapped core TFs identified by using <italic>Coltron</italic> and <italic>CRC mapper</italic> across 22 major tissues</title>
        </caption>
        <media xlink:href="mmc3.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc4">
        <caption>
          <title>Table S3. All CRC networks identified by <italic>Coltron</italic></title>
        </caption>
        <media xlink:href="mmc4.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc5">
        <caption>
          <title>Table S4. All CRC networks identified by <italic>CRC mapper</italic></title>
        </caption>
        <media xlink:href="mmc5.xls"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc6">
        <caption>
          <title>Document S2. Article plus supplemental information</title>
        </caption>
        <media xlink:href="mmc6.pdf"/>
      </supplementary-material>
    </p>
  </sec>
  <ack id="ack0010">
    <title>Acknowledgments</title>
    <p id="p0215">This work was supported by the <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source> (62001145, 62171166, and 62272212), the <funding-source id="gs2">Natural Science Foundation for Distinguished Young Scholars</funding-source> of Heilongjiang Province of China (JQ2020C004), the Research Foundation of the <funding-source id="gs3">First Affiliated Hospital of University of South China</funding-source> for Advanced Talents (20210002-1005 USCAT-2021-01), Wu Liande Youth Science Research Fund of <funding-source id="gs4"><institution-wrap><institution-id institution-id-type="doi">10.13039/100010722</institution-id><institution>Harbin Medical University</institution></institution-wrap></funding-source> (Daqing) (JFWLD202001), and the <funding-source id="gs5"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100002858</institution-id><institution>China Postdoctoral Science Foundation</institution></institution-wrap></funding-source> (2019M661311).</p>
    <sec id="sec5">
      <title>Author contributions</title>
      <p id="p0220">C.L., C.S., and C.F. designed the subject, wrote and revised the manuscript. Y.J. and Y.W. built the database. J. Zhang, J. Zhao, and M.Y. finished the figures. J. Zhu, B.A., and Q.W. conducted the experiments. F.Q., Y.Z., D.S., and J.L. processed the data.</p>
    </sec>
    <sec sec-type="COI-statement" id="sec6">
      <title>Declaration of interests</title>
      <p id="p0225">The authors declare no competing interests.</p>
    </sec>
  </ack>
  <fn-group>
    <fn id="appsec1" fn-type="supplementary-material">
      <p id="p0230">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.omtn.2023.03.014" id="intref0045">https://doi.org/10.1016/j.omtn.2023.03.014</ext-link>.</p>
    </fn>
  </fn-group>
</back>
